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General Introduction
1.1 INTRODUCTION
The history of autogenous bone grafting goes back to the nineteenth century. In 
1821 VON WALTER was probably one of the first surgeons who used autogenous 
corticocancellous bone grafts to reconstruct lost parts o f the maxillofacial skeleton 
(cited in HABAL and REDDI 1987, DE BOER 1988). Until the present day the use of 
autogenous bone grafts is still considered as the standard in reconstructive oral and 
maxillofacial (OMF) surgery (BURCHARDT 1983, CUTTING et al. 1984, HABAL 
1992a). These grafts can be used to augment the severely atrophic edentulous 
alveolar ridges, to reconstruct alveolar defects in cleft palate patients, or to bridge 
defects that are the result o f ablative surgery or trauma. Autogenous bone grafts, 
when adequately fixed, usually adapt to the recipient site and incorporate well into 
the defects. A layer o f connective tissue will mostly cover the grafts while from the 
interface between the recipient bone and the graft revascularisation takes place 
ultimately leading to the formation of new bone (URIST 1980). Fresh autografts 
contain surviving cells and inductive proteins, which can stimulate osteogenesis. 
From a biological point o f view, it is the best material available since it is non- 
immunogenic and it partially retains its viability immediately after transplantation. 
Alloplastic bone substitutes on the other hand, which are also commonly used as 
graft material, provide at best a scaffold for bone formation (ISAKSSON 1992).
The limited availability, the sometimes unpredictable resorption, the need 
for a second operation site, the time consuming procedure, donor site morbidity, the 
quantity o f bone available and the increased costs o f hospitalisation, has led to a 
search for alternatives. It is, therefore, the aim of the current study to gain insight 
into the healing capacity o f three types o f grafts with the idea to ultimately produce 
a graft that would alleviate or minimize the need for autogenous bone grafts.
1.2 MECHANISMS OF BONE GRAFT HEALING
A prerequisite for a bone graft to serve its purpose is healing. Many factors 
influence this healing process, which may also be considered as a kind of bone 
regeneration (GLOWACKI et al. 1981, MUTHUKUMARAN and REDDI 1985, SALIBIAN 
et al. 1987, CONNOLLY et al. 1989, WEILAND et al. 1990, HOLLINGER 1993). The 
healing process is complicated and involves factors like bone metabolism, changes 
in hormonal balance and external influences that are present for a prolonged time 
(HABAL and REDDI 1987). Revascularisation is mandatory for graft healing as 
newly formed blood vessels enable nutrients and humoral substances to be brought 
into the graft (LOZANO et al. 1976, LEE and LANGER 1983). If  revascularisation is 
successful new bone is formed around the transformed osteocytes at the margins of
11
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Table 1.1 Mechanisms o f bone healing (GLOWACKI 1992)
Type Physiologic principle Examples of materials
Osteogenesis Transplantation of viable osteoblasts Cancellous bone, marrow, periosteum
and preosteoblasts and vascularized grafts
Osteoconduction Ingrowth of bone from the margins of Cortical segments; banked allogenic
defect with gradual resorption of or xenogenic bone; resorbable
implant materials
Osteoinduction Phenotypic conversion of 
mesenchymal cells into bone cells
Demineralized bone and dentin
the graft and the old bone is slowly replaced. This process is called ‘creeping 
substitution’. Cancellous bone allows the easy penetration whereas cortical bone is 
more difficult to penetrate for capillaries (BURCHARDT and Enneking  1978, E itel 
et al. 1980, KUSIAK et al. 1985, A rden  and BURGIO 1992, HABAL 1992a). On the 
other hand, the volumetric maintenance of cortical bone grafts is superior to that of 
cancellous bone (Sm ith  and A bram son  1974, Z ins and W hitaker  1983, W ilkes 
et al. 1985, DADO and IZQUIERDO 1989, PHILIPS and RAHN 1990). 
Corticocancellous bone usually produces the best results because it has 
characteristics o f both. It enables adequate revascularisation and thus enhances 
incorporation of the graft into the surrounding structures and it also possesses 
mechanical strength. Differences in healing between several cortico-cancellous 
donor sites are related to the three dimensional osseous architecture (the 
cortical/cancellous ratio) rather than to the embryonic origin per se (membranous 
versus endochondral bone) (HARDESTY and MARSH 1990).
Osseous healing is achieved by direct osteogenesis, via osteoinduction or 
via osteoconduction (GLOWACKI 1992) (table 1.1). These mechanisms are not 
separate and distinct, but overlapping (MISCH and D ietsh  1993). Understanding 
these processes enables the surgeon to make the most appropriate selection for a 
particular application. Osteoinductive materials stimulate the differentiation of 
osteogenic cells from mesenchymal cells. Osteoconductive materials provide a 
permanent or resorbable scaffold for the ingrowth of bone from the margins o f the 
defect.
It is possible to determine which healing mechanism(s) is (are) stimulated 
by a material by examining its effects in osseous and ectopic, non-osseous, sites 
(GLOWACKI 1992) (table 1.2). If  implanted subcutaneously, osteoinductive 
materials elicit enchondral osteogenesis, whereas osteoconductive materials appear
12
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Table 1.2 Differences between osteoinductive and osteoconductive materials
(GLOWACKI1992)
Osteoinductive Osteoconductive
In ectopic implants,
Is bone formed? Yes No
In intraosseous implants,
What is geometry of healing? Field From margins
Is healing enchondral? Yes No
In onlay implants,
What is geometry of healing? Field From underlying bone
Is healing enchondral? Yes No
Examples Demineralized bone Porous particulate ceramics, 
collagen matrix
to be inert. The latter only provoke mild inflammatory reactions. Osteoconductive 
grafts allow ossification from the margins o f the defect combined with the 
resorption of the non-vital matrix. This process is similar to the formation of 
periosteal collarbone in fracture repair.
1.3 TYPES OF GRAFT MATERIAL
Per definition there are four types o f grafts, i.e. autografts, allografts, alloplasts and 
xenografts. The term autograft refers to tissue transplanted from one site to another 
within the same individual. Allografts are obtained from cadavers or living 
individuals from the same species. In human medicine they can be obtained from 
tissue banks (KÜBLER 1997). Alloplasts are synthetic materials consisting of 
biological inert substances. Xenografts are composed of tissue taken from another 
species (i.e. from an animal source, usually bovine). In case the organic material is 
removed from xenogenic bone, it may be considered as an alloplast (Ga rg  1999). 
The term ‘composite graft’ refers to grafts that are composed of materials from 
different origins, usually autogenous bone mixed with other materials (HABAL 
1991).
1.3.1 Autogenous bone grafts
Autogenous bone grafts may consist o f cortical or cancellous bone but usually a 
combination of both is used, called cortico-cancellous grafts. This type of graft is 
probably the graft most often used in reconstructive OMF surgery. The easier the
13
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penetration of blood vessels into the graft to revascularise it, the less mechanical 
stress the graft can take.
1.3.1.1 Cortical bone grafts
Pure cortical grafts have limited application. They may be used as onlay grafts in 
the maxillofacial skeleton. In order to serve their purpose the graft needs to be 
completely remodelled by creeping substitution for which adequate 
revascularisation is required. This in turn demands rigid fixation of the graft to the 
recipient bone because any micromovement may jeopardise this process. Typical 
applications include onlay grafts to the maxilla to improve infra-orbital or paranasal 
contour (HABAL 1992a). The most often used donor site is the cranial vault 
(especially in older patients) first described by TESSIER (1982). There is hardly any 
morbidity associated with this donor site even if  the dura is visualised or exposed 
(HABAL 1992b).
1.3.1.2 Cancellous bone grafts
Pure cancellous bone is commonly used in OMF surgery to fill bony defects such as 
alveolar clefts, for non healing fractures, around dental implant defects and other 
small osseous defects. Cancellous bone lacks the mechanical strength, desired for 
reconstruction of larger defects except when rigid appliances are used. Cancellous 
bone is used because of the ease o f its application and its ability to improve healing. 
The porous structure o f these grafts allows for rapid revascularisation, with cellular 
ingrowth and differentiation and subsequent remodelling and substitution. The most 
common donor sites for autogenous cancellous grafts are the anterior or posterior 
iliac crest or the tibial plateau.
1.3.1.3 Corticocancellous bone grafts
Cortico-cancellous bone grafts have a wide application in reconstructive OMF 
surgery. The cortical layer strengthens the graft, which implies that the graft can be 
contoured to fit the defect that needs to be filled or bridged. As a free graft it can be 
used to bridge a defect up to 5 cm provided adequate blood supply is assured from 
the enveloping soft tissues. Much larger cortico-cancellous bone grafts can be used 
when microvascular anastomoses guarantee the primary survival o f the graft. In 
most cases these grafts have also to be fixed rigidly to the surrounding bone to 
allow proper healing, while the patient can still function with a more or less intact 
jaw. Typical donor sites are rib, iliac crest, fibula or radius, whereas oral sites 
include chin, retromolar area and mandibular body.
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1.3.2 Allografts
The prim ary forms o f  allografts are frozen, freeze-dried (lyophilised), dem ineralized 
freeze-dried and irradiated bone. Because allografts are not osteogenic, bone 
form ation takes longer and results in less volum e com pared to autogenous grafts 
(MISCH and DIETSH 1993). They revascularize quickly but the risk o f  an antigen 
transm ission, especially in a high vascular area as the facial skeleton, increases the 
risk o f  rejection o f the graft. In the OM F area dem ineralized bone grafts can be used 
after irradiation.
The m ost com m only used allograft is dem ineralized and freeze-dried bone. 
The latter is used for m inim ising the antigenicity (BLOCK and POSER 1995), 
resulting in a dem ineralized bone m atrix (DFDBA). In 1965, URIST (1965) reported 
that dem ineralized bone and dentin provide postem bryonic osteoinductive stimuli 
and that this m aterial is capable o f  inducing ectopic bone form ation w hen im planted 
subcutaneously or into m uscle pouches in rodents. REDDI and HUGGINS (1972) 
found that im plantation o f particles o f  dem ineralized bone resulted in  the induction 
o f enchondral bone. This enchondral osteogenesis is sim ilar to the process occurring 
in em bryonic skeletogenesis, grow th o f long bones and healing o f  fractures (REDDI 
and HUGGINS 1972, URIST 1973, REDDI et al. 1987, HAMMONDS et al. 1991, 
SASANO et al. 1993). Successful experim ents in anim al studies led to the clinical 
application o f  DFDBA, w ith satisfactory results particularly in small defects 
(G lo w a ck i et al. 1981, M u llik en  et al. 1981, KABAN et al. 1982, SONIS et al. 
1983, Glo w a ck i and M u llik en  1985, M a x so n  et al. 1990). In larger defects the 
results are reproducible in children, but not in adults (HABAL 1992b). In hum an 
sinus floor elevation procedures, allogenic D FD BA  increases m ineralised tissue 
volum e m ainly by  osteoconduction, supported by  rem ineralisation but not 
osteoinduction (GROENEVELD et al. 1999a).
1.3.3 Alloplasts and xenoplasts
A  m ajor category o f grafting m aterial consists o f  an anorganic m atrix either 
obtained by  sintering calcium  phosphates such as tricalcium  phosphate (TCP) or 
hydroxyapatite (HA), or consisting o f  deproteinized bovine bone m ineral (BBM ) or 
derived from  the natural exoskeleton o f reef-building sea coral. A norganic 
alloplastic bone m inerals, i f  used alone, are osteoconductive and consequently do 
not have the capacity to bridge critical size m axillofacial defects (BOYNE 1991). 
Nevertheless, they have been used for a variety o f  indications such as periodontal 
defects (BOWEN et al. 1989), alveolar clefts (El D eeb  et al. 1989), facial contour 
corrections (SALYER and HALL 1989, ROSEN and MCFARLAND 1990) and alveolar
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ridge augmentations (HOLMES and HAGLER 1988, MERCIER et al. 1992). Numerous 
problems have been reported such as fracture, infection and exfoliation of the 
implanted material (Hupp and KENNA 1988, ROONEY et al. 1988, PIECUCH et al.
1990, SCHLIEPHAKE and NEUKAM 1991). These complications have been attributed 
to the fact that the grafts are devoid of living tissue and that they can only be used in 
uncompromised recipient beds (Siebert et al. 1986). It has been shown that the rate 
of bone ingrowth can be increased by using a resorbable membrane to allow for 
guided bone formation inside subperiosteally implanted HA blocks (SCHLIEPHAKE 
et al. 1994).
1.3.3.1 Tricalciumphosphate and Hydroxyapatite
Sintered calcium phosphate ceramics, particularly a-TCP and HA, are the anorganic 
graft materials most often used in OMF surgery. The rationale for their use is found 
in their biochemical and structural similarity to the mineral phase of bone. Both 
materials are available as solid or porous block, chips, or granules. Each has 
markedly different physical and degradative properties, strongly dependent on the 
structure (i.e. solid versus porous), its micro structure and the presence of minor 
impurities. In general, a-TCP is degraded within days or weeks after implantation, 
whereas high-density crystalline HA is irresorbable or its degradation may take 
years (HOLMES et al. 1984, SHIMAZAKI and MOONEY 1985, BUCHOLZ et al. 1989, 
NAGAHARA et al. 1992).
TCP is sintered into polycrystalline porous ceramics. Histological studies of 
a-TCP ceramic implanted in human osseous defects showed excellent tissue 
compatibility but no new bone formation (BALDOCK et al. 1985). However, a 
histological study of biopsies of soft tissues removed from defects filled with a- 
TCP revealed osteoid forming alongside and within many of the ceramic particles 
(FRANK et al. 1985). Viable mature bone fragments were found separate from the 
ceramic material (BOWERS et al. 1977, NAAMAN-BOU-ABBOUD et al. 1994). One of 
the drawbacks of a-TCP, however, is that it resorbs faster than it can be replaced by 
newly formed bone (REIDA et al. 1977, Nery et al. 1978). Probably this is the 
reason why only studies with a-TCP in small defects have been published, such as 
periodontal lesions (HASHIMOTO et al. 1995). Changes in the chemical structure of 
the material (P-TCP form) that are recently introduced, reduce the resorption rate 
and intend to provide a physical matrix suitable for deposition of new bone (MISCH 
and DIETSH 1993).
HA is, similar to a-TCP, synthesised by a procedure that results in a 
crystalline spatial structure close to that of cortical bone matrix (DESJARDIN 1985).
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Its degradation does not start before 9 m onths after im plantation (K ent  et al. 1983, 
BUCHOLZ et al. 1987, BRAYE et al. 1996). Various authors studied the use o f  HA. 
They considered its slow resorption relative to the characteristic tim e span for bone 
regeneration, to be either an asset (H e r r  et al. 1993) or a liability (D oll et al. 
1990). In biopsies taken one year after m andibular ridge augm entation w ith a 
com posite o f  HA particles in a m atrix o f  purified fibrillar collagen, the HA particles 
appeared to be surrounded by  dense fibrous connective tissue and trabeculae o f 
w oven and lam ellar bone (M eh lisc h  et al. 1990). This com bination was found to 
be biocom patible w ith  hum an tissue and receptive o f  direct bone apposition on the 
HA particles. A n argum ent against HA is that as long as it m aintains its m echanical 
strength, the bone that is form ed w ithin the porous netw ork o f the HA scaffold is 
stress shielded and, therefore, does not undergo m echanical loading that acts as a 
trigger for rem odelling. Long-term  persistence o f rem odelling bone w ould be more 
likely to occur i f  the initial scaffold w ould gradually degrade allowing the bone to 
be loaded. A n argum ent in favour o f  HA is that its structure resem bles natural 
hydroxyapatite m ore closely than TCP does and, therefore, it m ight represent a 
better scaffold for bone ingrow th (HAERS et al. 1991, YASZEMSKI et al. 1996).
1.3.3.2 Bovine Bone Mineral (BBM)
BBM  is derived from  bovine bone. The structure consists o f  a w ide interconnective 
pore system  that can easily be invaded by  blood vessels resulting in  osteoblastic 
migration. BBM  contains pores o f  different sizes: m acropores (300-1500 ^m ), 
m icropores (H aversian and vascular m arrow  canals) and intracrystalline spaces (3­
26 nm ) (PEETZ 1997). This results in an overall porosity o f  70%  to 75%, reaching a 
surface area o f  almost 100 m  /g. N o other current com m ercially available synthetic
m aterial shows this high porosity (HÄMMERLE et al. 1997): e.g. synthetic HA
2 2  reaches a surface area o f  approxim ately 1 -  10 m  /g and natural coralline 3.1 m  /g
(W h ite  and Shors  1986, Peetz  1997).
BBM  is therm ally and chem ically treated in order to extract organic 
constituents and thereby elim inating its antigenicity and potential inflam m atory 
response by  the recipient (H islo p  et al. 1993, COHEN et al. 1994). Some authors, 
however, reported that BBM  still contains collagen type I fibres, w hich m ight cause 
antigenic reactions (L in sem a y er  1981). Antibodies against bovine collagen are 
rare and, therefore, are unlikely to be responsible for graft failure (De  LUSTRO et al.
1990). On the other hand, collagen I m ight stimulate the prim ary attachm ent o f 
osteoblasts by  an interaction w ith the ß-1 integrin subunit o f  the pre-osteoblast 
resulting in  a faster bone deposition as com pared to HA (Ba sle  et al. 1998).
17
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BBM  is prone to resorption by  osteoclasts or m ultinucleated giant cells 
(PINHOLT et al. 1991, DERSOT et al. 1995) although other studies refute this 
(MANDELKOW et al. 1990, STASSEN et al. 1994, SKOGLUND et al. 1997, YOUNG et 
al. 1999). Contrary to HA, w hich is not replaced by  bone, because it does not 
resorb, the resorption o f BBM  finally  leads to substitution and rem odelling.
1.3.3.3 Coralline
A nother hydroxyapatite structure is derived from  coral (Porites spec.). The calcium  
carbonate skeleton is converted for 90%  into HA, 3%  rem ain calcium  carbonate and 
the rem ainder consists alm ost entirely o f  TCP (HOLMES et al. 1987, MARTIN et al. 
1989). It has fully interconnected pores o f  100 -  500 ^m  in diam eter and a surface 
to volum e ratio o f  3.1 m /g  providing an good m atrix for bone ingrow th by 
osteoconduction (W hite  and SHORS 1986). It has been used in bone regeneration 
studies w ith varied success (HOLMES et al. 1987, DOLL et al. 1990). The 
resorbability o f  this m aterial is questionable (MARTIN et al. 1993, 
PAPACHARALAMBOUS and A n a sta so ff  1993, POLLICK et al. 1995, BRAYE et al. 
1996).
BUCHOLZ et al. (1997) dem onstrated bone healing in 46 cases o f  nonhealing 
fractures o f  m etaphyseal and diaphyseal bones treated w ith coralline. One o f the 
m ajor disadvantages o f  coralline as an im plant m aterial is its initial weakness (55%  
o f cancellous bone strength) (BUCHOLZ et al. 1987, MURPHY et al. 1992) and the 
difficulty o f  handeling it (A sh m a n  1992). This excludes its use in cases in  w hich 
the initial m echanical load has to be borne by  the graft alone (SARTORIS et al. 
1987). A fter bone ingrowth, the m echanical properties o f  coralline im plants are 
dram atically improved. Six m onths after im plantation its strength is 1,5 -  3 times 
that o f  a cancellous autograft (BUCHOLZ et al. 1987).
1.3.3.4 Active glass ceramics
Bioactive glass ceram ics (Bioglass, Perioglass, Biogran) are com posed o f  calcium  
salts and phosphates in sim ilar proportions as found in bone and teeth, as w ell as 
sodium salts and silicates w hich are essential for bone m ineralisation. PerioGlas is 
the particulate form  o f Bioglass. B iogran is a soluble, hydrophilic and slightly 
hem ostatic pow der m ade o f bioactive glass granules. The ceramic is available as an 
am orphous m aterial that shows m ore favourable properties than the crystalline 
form, w hich is believed to degrade faster under the influence o f tissue fluids by 
physical-chem ical reactions. Because it is not porous, release o f  silicates and 
ingrow th o f blood vessels and other tissue com ponents into the m aterial is not
18
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possible. WILSON and NOLETTI (1990) mentioned two properties contributing to its 
usefulness: (1) the relatively fast host cells reaction and (2) the ability to bind to 
connective tissue collagen. The bioactivity of Bioglass may stimulate the reparative 
process (Fetner et al. 1994) which give rise to a relative short time needed for full 
bony ingrowth as compared to HA (OONISHI et al. 1997).
These materials are mainly applied in periodontal defects (ZAMET et al. 
1997, Lovelace et al. 1998, Froum et al. 1998), pre-implant mandibular osseous 
defects (Schepers et al. 1998), and peri-implant defects (HALL et al. 1999). There 
is only one study comparing bioactive glass particles with autogenous bone grafts in 
patients with skeletal deformities of the face after trauma or tumour surgery. 
Clinical and radiographical (without histological) examination showed no ‘relapse’ 
of the aesthetic result in both groups after one year follow-up (Suominen and 
KINNUNEN 1996).
1.3.4 Composite grafts with autogenous bone
Per defenition a composite graft is composed of materials from different origin. 
Several attempts have been made to accelerate their healing process, by adding 
autogenous cancellous bone (COBB et al. 1990) or using electrical stimulation (Lew 
and MARINO 1991) but also by adding growth factors (BMP) (KAWAMURA et al. 
1987, RIPAMONTI 1991) or platelet rich plasma (PRP) (MARX et al. 1998). LANG 
and Mertens (1990) even tried to implant cultured homologous osteoblast-like 
cells in alloplastic scaffolds with success. All these attempts were ment to reduce 
the volume of autogenous bone needed and to accelerate the bone healing. It also 
may improve the efficiency and may even prevent resorption, possibly resulting in a 
dense new bone formation (MISCH and Dietsh 1993, SATOW et al. 1997).
Osteoconductive and osteoinductive materials may also be used in 
combination with autogenous bone. In case of an alloplastic material this is ment to 
be osteoconductive as to allow migration of capillaries and cells into the pores 
resulting in deposition of new bone (HAERS et al. 1991, SATOW et al. 1997). HA 
particles in conjunction with autogenous cancellous bone appeared to be excellent 
grafting material because it enhances the osteoconduction and fastens the 
solidification (VANASSCHE et al. 1988) while HA alone does not (WANGERIN et al. 
1985). HABAL (1991) used composites of HA, autogenous corticocancellous bone, 
temporalis fascia slivers, fibrillar collagen, blood and antibiotics in cleft alveolus 
surgery in children between the ages of 6-21 years. His results showed no changes 
or interferences with growth of the facial skeleton of these children. The results,
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however, w ere som ewhat com prom ised by  the sim ultaneous use o f  orthodontic 
appliances during the healing phase.
A t present, no studies have been reported on com posite grafts consisting o f 
autogenous bone and BBM.
R ecom binant hum an bone m orphogenetic proteins (rhBM P), osteogenic 
proteins (OP), or autogenous platelet derived grow th factors (PDGF) can be added 
to com posite grafts. It m ight be a reasonable alternative to autogenous bone grafting 
in osseous reconstructive procedures, circum venting the lim itations o f  donor bone 
supply and the risk o f  complications. M any osteoinductive factors have been added 
to com posite grafts in several experiments. The results indicate that the com bination 
o f any com posite graft w ith a BM P has the greatest potential for regeneration o f 
experim ental bony defects (DAMIEN et al. 1990, DOLL et al. 1990, RIPAMONTI et al. 
1996). A t present, the A m erican Food and Drug A dm inistration (FDA) has not 
registered rhBM P and, therefore, the experience is still in a phase II stadium. The 
results appear to be som ewhat unpredictable (GROENEVELD et al. 1999b). 
Inform ation concerning the efficacy and safety o f  rhBM P or OP, however, is 
essential for the design o f future hum an applications. The use o f  dem ineralized 
allogenic or xenogenous bone m ay contain the risk o f  host pathogen transm ission. 
The construction o f collagenous m atrices in w hich osteoinductive proteins are 
em bedded w ould result in an inconsistent perform ance, a lim ited supply and 
tenuous inductive ability (GROENEVELD et al. 1999a). The use o f  autogenous 
platelet-rich plasm a (PRP), w hich contains PDGF and transform ing grow th factor 
(TGF-^1 and -^2) seems more prom ising (MARX et al. 1998).
1.4 MODES OF APPLICATION.
Grafts can be used in  large pieces called ‘b locks’ or m ay be m anufactured or cut 
into small particles. Both forms can be obtained in a dense and a porous form  
referring to the m icrostructure o f  the graft. A ll types o f  graft m aterial can be 
delivered in blocks. Blocks are usually  shaped before application to precisely fit the 
defect and to bear lim ited m echanical stress. They are com m only used to restore 
continuity for exam ple in m andibular reconstructive surgery. W hen autogenous 
grafts are used for this purpose the supply is som ew hat limited. Particulate grafts 
are com posed o f small irregular chips easily obtained by  cutting block grafts into 
chips by  milling (ISAKSSON 1992). This type o f  graft is usually applied in areas 
where little m echanical strength is needed. It can be used to fill small defects, to 
correct m inim al contour irregularities and for packing around larger grafts. The chips 
are usually o f  different shape and size and m ay facilitate and promote bone
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regeneration (HABAL 1992a). Since the introduction o f  im proved rigid fixation 
techniques, chips can also be used for larger defects. Trays offer an excellent means 
o f holding particulate, autogenous grafts in the desired contour (B o y n e  1983, 
A lbert  et al. 1986, L ea k e  et al. 1992, Ch e u n g  et al. 1994, T id em a n  et al. 1998). 
As a consequence, the patient can have near-norm al function during the healing 
phase, w hich m ay take as long as 2 years.
1.5 MICROSTRUCTURE OF THE GRAFT
Grafts, but particularly alloplasts, exhibiting large inner surface areas, are better 
recipient sites for bone ingrow th than m aterials w ith a com paratively small surface 
area (Fra m e  et al. 1987, HOLMES and ROSER 1987, KASPERK et al. 1988). The 
penetration o f  host bone into the inner part o f  the graft m aterial is related to the 
porosity o f  the m aterial (HOLMES and ROSER 1987, KASPERK et al. 1988, DACULSI 
and PASSUTI 1990, VAN EEDEN and RIPAMONTI 1994, HÄMMERLE et al. 1997).
Cortical bone is com posed o f a dense osteoid m atrix and, therefore, difficult 
to penetrate by  new  blood vessels. Even years after application only the interface is 
the area that is revascularised, w hile the rem ainder o f  the cortical com ponent m ay 
stay non-vital. In cancellous grafts, however, large open areas enable 
revascularisation very  well, bringing cellular regeneration, resulting in a 
rem odelling and substitution, w ith new  bone form ing as old bone is resorbed. The 
m ore dense the bone graft, the harder it is to be revascularised, to becom e 
incorporated, and to rem ain viable or to becom e replaced by  viable bone by 
creeping substitution (HARDESTY and MARSH 1990, SULLIVAN and SZWAJKUN
1991, Philips  and Ra h n  1992).
Ceramic calcium  phosphate m aterials can be delivered in dense and porous 
forms o f blocks and particles. A  general disadvantage o f  porous ceram ic blocks is 
that their strength decreases exponentially w ith the increase in  porosity. Blocks 
have a high com pressive strength but are brittle; thus they are not considered 
suitable for load bearing (GARG 1999). Hydroxyapatite (HA) particles, instead o f 
blocks HA, are less brittle and circumvent this problem. Porous HA blocks have been 
used as an alternative to HA particles (Fra m e  1987). BOYNE (1991) noted a decrease 
in the clinical use o f  non- resorbable, nonporous HA for alveolar ridge augmentation 
and an increase in the use o f porous HA because the non-resorbable form tends to 
lack cohesive strength, w hilst the particles migrate under stress during the healing 
process. The use o f  porous HA blocks, however, m ight result in m echanical fragile 
areas i f  used to fill defects in the cortex o f  long bones or thin m andibles 
(YAMAGUCHI et al. 1995).
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1.6 EXPERIMENTAL SET-UP AND AIM OF THE STUDY
The experim ental m odel chosen to test bone grafts or bone substitutes should 
preferably have sim ilar physiologic properties as the clinical site where it w ill be 
used. M ost o f  the tests on grafting m aterials are perform ed in anim al calvaria. This 
has been shown to be a reproducible m odel (SIROLA 1960, GLOWACKI et al. 1981, 
Reid  et al. 1981, TAKAGI and URIST 1982, PROLO et al. 1982, ISAKSSON 1992, 
KLINGE et al. 1992). The calvarial m odel has m any sim ilarities to the m axillofacial 
region. Both the calvaria and the facial bones develop by  m em branous bone 
deposition and show m orphological and em bryological sim ilarities (SCHMITZ and 
HOLLINGER 1986). In calvarial bone m orphogenesis and healing, however, the dura 
plays a role because o f its osteoinductive capacity m aking it an osteogenic site 
(HOBAR et al. 1993, Gu zel  et al. 1995, HOBAR et al. 1996, Yu  et al. 1997). In the 
facial skeleton respiratory epithelium  is involved w hich is not osteoinductive and 
thus represents a non-osteogenic site. This respiratory epithelium  in the growing 
individual acts as a resorptive endosteum , leading to an increase in overall size o f 
the (para)nasal sinuses (ZINS et al. 1984). It is, therefore, questionable w hether the 
calvaria is a suitable research m odel for OM F surgery, as bone grafts are often used 
to bridge gaps overlying a paranasal sinus w ith respiratory epithelium  as a lining. In 
this thesis the frontal bone (over the frontal sinus) o f  young adult fem ale goats as 
experim ental site is chosen. This sinus has a large volum e lying betw een the orbits. 
The m ucosal lining is consists o f  a ciliar epithelium , sim ilar to the m axillary sinus. 
Four full thickness standardized defects can be m ade under general anaesthesia w ith 
a trephine. In  a pilot study defects w ith a diam eter o f  14 m m  showed to be o f 
critical size, w hich m eans they  w ill not heal spontaneously. The selected site 
enables the study different grafting m aterials in one animal.
In the present experim ental study BBM  w as chosen as an alternative for 
autogenous bone because this m aterial has norm al osseous porosity and undergoes 
progressive resorption w hen used as a bone substitute (BOYNE 1992). It also gives 
rise to the deposition o f lam ellated bone because o f its osteoconductive capacity and 
it eventually w ill be resorbed. There are, however, no studies available on the 
behaviour o f  a com posite graft consisting o f autogenous bone and BBM. This study 
was designed to gain further insight in graft healing in general in the m axillofacial 
area w ith an emphasis on the mode o f  application (block graft versus particulate 
grafts). The prim ary aim w as to study the healing o f autogenous cancellous and 
cortical bone grafts alone and in com posite grafts using BBM  in  a new, standardised 
anim al model.
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W hen considering the use o f  grafts in the m axillofacial area, alveolar cleft 
defects im m ediately come into mind. These sites require grafts that allow  teeth to 
erupt (clefts). To study the eruption o f  teeth through bone grafts, an experim ental 
m odel has to fulfil several requirem ents. The experim ental animals m ust have 
preferable two generations o f  teeth, a deciduous and a perm anent one. The 
developm ent o f  the teeth has to start in the postnatal period and it has to be slow 
enough to allow  accurate docum entation by  m eans o f large series o f  radiographs. 
The animals have to be large enough to m ake standardized radiographs o f the 
developing teeth and the m andibles possible w ithout superposition o f other 
structures. The experim ental animals m ust have a know n background, and the 
norm al grow th and developm ent o f  the anim als has to be w ell documented. Finally 
they m ust be easy to handle. Dogs, and especially beagles fulfil m ost o f  these 
requirem ents. The use o f  fem ale dogs only is based on the data reported by 
MALTHA (1982). It is shown that sex differences in the pattern o f  em ergence exist 
and that the variation in the age o f  em ergence o f different teeth in fem ales is sm aller 
than in m ales (KREMENAK 1967).
A nother w ell know n reason for bone grafting in the OM F area is ‘sinus 
floor augm entation’ . These sites form  an adequate environm ent for endosteal 
implants, to create a fixation for a dental prosthesis. The final aim  o f the study was 
to review  the current clinical literature w ith regard to various anorganic m aterials 
and alloplasts used for sinus floor grafting.
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ABSTRACT
The regenerative response on autogenous cancellous and cortical bone grafts, and 
on a com m ercially available xenogenous bovine bone m ineral (BBM ) (Bio-Oss®, 
Geistlich-Pharm a, W olhusen, Switzerland) was com pared in standardized bony 
defects related to a paranasal sinus.
On 15 skeletally m ature goats four critically size full thickness bone defects were 
trephined in the frontal bone. These defects were filled at random  w ith a cortical 
bone plug, a cancellous bone plug, a plug o f spongeous BBM  cut into shape or left 
empty. Fluorochrom e bone m arkers were injected subcutaneously 1 and 5 weeks 
after transplantation and one w eek before the animals were sacrificed. This took 
place 3, 6, 12 and 24 weeks after surgery.
H istological evaluation showed that autogenous bone grafts were all accepted and 
incorporated in a sim ilar w ay as in calvarial defects. BBM  w as only 
osteoconductive. N ew  bone was form ed at the m argins o f  the defects, and only little 
o f  the BBM  was incorporated. M ost o f  the BBM  was gradually resorbed by 
m ultinucleated osteoclast-like cells.
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2.1 INTRODUCTION
Several forms of autogenous bone transplants have been used in attempts to achieve 
rapid and proper bone healing in facial reconstruction (SALYER and TAYLOR 1987). 
Allografts and xenografts (e.g. deproteinized bone) or other bone substitutes (e.g. 
glass tubes, ceramics and plastics) which also are commonly used as graft material, 
only may provide a scaffold for bone formation (URIST 1980, ISAKSSON 1992).
In oral and maxillofacial surgery (OMS), gap bridging over a paranasal 
sinus with autogenous bone grafts is the 'accepted standard' (HABAL 1992). Two 
different types of autogenous bone grafts are most often used: cortical and 
cancellous. Each type has advantages and disadvantages based on differences in 
architecture of the graft itself (Smith and ABRAMSON 1974, BURCHARDT and 
ENNEKING 1978, Eitel et al. 1980, SULLIVAN and SZWAJKUN 1982, ZINS and 
WHITHAKER 1983, Kusiak et al. 1985, WILKES et al. 1985, DADO and IZQUIERDO
1989, HARDESTY and MARSH 1990, PHILIPS and RAHN 1990, 1992, ARDEN and 
BURGIO 1992).
Various allogenous and alloplastic materials have been developed to avoid 
the problems related to harvesting autogenous bone grafts. These materials are 
supposed to enhance bony ingrowth in non-weight-bearing gap and revision 
models, although they do not have bone inductive capacities.
Most of the tests on bone grafting materials are performed in animal 
calvaria. This has shown to be an accurate and reproducible mode (SIROLA 1960, 
Glowacki et al. 1981, Reid et al. 1981, PROLO et al. 1982, TAKAGI and URIST 
1982, ISAKSSON 1992, KLINGE et al. 1992). The calvarial model has many 
similarities to the maxillofacial region as acceptor site. Both the calvaria and the 
facial bones develop by membranous bone deposition and show morphological and 
embryological similarities (SCHMITZ and HOLLINGER 1986). In calvarial 
morphogenesis and bone healing the dura plays a central role (ISAKSSON 1992, 
HOBAR et al. 1993, Guzel et al. 1995, Yu et al. 1997). However, in the 
morphogenesis of the facial skeleton not dura but respiratory epithelium is involved. 
Bone grafts in OMS are usually used to bridge gaps overlying a paranasal sinus 
with respiratory epithelium as underlining. This respiratory epithelium normally 
acts as a resorptive endosteum, leading to an increase in overall size of the 
(para)nasal sinuses (ZINS et al. 1984).
Therefore the purpose of this study was to evaluate bone healing in the 
facial skeleton overlying a paranasal sinus in response to autogenous cancellous and 
cortical bone grafts, and a commercially available xenogenous bovine bone mineral
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Fig 2.1 Schematic drawing o f  the (prepared) 
skull o f  a goa t with trephine holes over the 
frontal sinus (CHA TELAIN1987)
(BBM) (Bio-Oss@, Geistlich-Pharma, Wolhusen, Switzerland).
2.2 MATERIAL AND METHODS
The study was performed on 15 skeletally mature female Dutch milk goats (Capra 
Hircus Sana) of about 2 years of age and weighing about 60 kg. Under general 
anaesthesia a cancellous bone plug was harvested from the anterior iliac crest with a 
trephine (inner 0  14 mm). In a similar way a cortical bone plug was removed from 
the caudal mandibular margin, without avulsing the mandibular nerve. Both bone 
plugs were stored in sterile 0.9% NaCl solution. The third type of material used in 
this research was Bio-Oss@ (Geistlich-Pharma, Wolhusen, Switzerland), delivered 
as a spongiosa block measuring 1x1x2 cm. It was cut into a circular plug ( 0  14 
mm, 0.5 cm thick) and stored in sterile 0.9% NaCl solution as well.
A longitudinal midsagittal incision was made over the snout. Four full 
thickness bone defects were made in the frontal bone with a trephine (outer 0  14 
mm) overlying the frontal sinus leaving the mucosal lining and its fibrous 
attachment to the inner table around the defect intact (fig 2.1). In each animal the
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Fig 2.2 Radiograph of a frontal bone specimen, 3 
weeks after transplantation, with tantalum implants 
around the defects. 1 = Control, 2 = Cancellous bone 
graft, 3 = BBM sponge, 4 = Cortical bone graft
defects were filled at random  w ith one o f the im plant m aterials or left empty. Prior 
to the im plant procedure m etal bone m arkers were inserted by  the m ethod o f BJÖRK 
(1955), one adjacent to each defect to facilitate orientation at sectioning o f 
histological specim ens and to im prove radiographic evaluation. The periosteum  was 
repositioned and the incision closed w ith resorbable sutures.
For the histological study, fluorochrom e bone m arkers w ere injected 
subcutaneously 1 w eek (Tetracycline 20 mg/kg), 5 w eeks (Xylenol Orange 90 
m g/kg) after transplantation, and one w eek before the animals w ere given up 
(Calceine 7 mg/kg).
Groups o f 3 anim als were sacrificed at 3, 6, or 12 weeks and 6 animals at 
24 weeks after surgery w ith a lethal dose o f pentobarbitone after norm al anaesthetic 
induction procedures. B lock resection o f the frontal bone w as perform ed. A fter 
stripping all soft tissue they were stored in 4%  0,1 M  phosphate-buffered 
form aldehyde for fixation. Contact radiographs were obtained by  placing the frontal 
bone specim en paranasal side down on a 5 x  7 cm intraoral film  (Kodak Ektaspeed)
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using a radiographic apparatus (Philips Oralix), set at 70 kV, and an exposure time 
o f 0.7 seconds.
A fter fixation, the explants were divided into sm aller specim ens in such a 
w ay that each experim ental site was split into two halves. One h a lf was decalcified 
in 20%  form ic acid and 5%  sodium citrate, dehydrated and em bedded in Paraplast® 
(Sherwood M edical, St. Louis, U .S.A .) (WIJDEVELD et al. 1991). Serial sections, 7 
^m  thick, were cut transversally in the m idpart o f  the lesion and stained w ith 
haem atoxylin and eosin. The other h a lf o f  each defect was em bedded in PM M A 
w ithout decalcification and 30 ^m  sections were obtained using a Leitz 1600 
rotating w ater-cooled diam ond saw. These sections rem ained unstained. Two 
observers evaluated all sections.
2.3 RESULTS
2.3.1 Macroscopical and morphological assessment
H ealing w as uneventful in all instances w ithout any signs o f  infection or wound 
dehiscences. Palpation o f the defects in sacrificed animals revealed that after 3 
weeks trephine rim s o f the em pty defects were still marked, and after 6 weeks they 
were m ore rounded. A fter 12 and 24 weeks a tight sheet crossed the defect. The 
autogenous cortical and cancellous bone plugs were rigidly fixed in all animals. The 
BBM  grafts also seem ed to be fixed in the trephine defect at 3 and 6 weeks. A fter 
12 and 24 weeks, however, hardly any BBM  could be detected in the centre o f  the 
defect.
2.3.2 Radiographic analyses
The radiographs did not reveal any difference betw een the two types o f  autogenous 
grafts at any time. The original cortical or cancellous radiologic structure was still 
detectable after 3 w eeks (fig 2.2). A ll im plants seem ed w ell am algam ated to the 
surrounding bony margins. The control defects showed no healing after 3 weeks but 
at the edges o f  some defects new  bone m ineralization was observed at later times. 
A fter 3 and 6 weeks the defects treated w ith BBM  were nearly  com pletely filled 
w ith m ineralised tissue. A lthough BBM  was less radiopaque after 6 w eeks than 
after 3 weeks, the BBM  structure was still identifiable. A fter 12 weeks tissue w ithin 
the defects was not com pletely m ineralised anymore and after 24 w eeks the am ount 
o f  m ineralised tissue w ithin the defect had decreased further, suggesting resorption 
o f the implant.
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Fig 2.3a BBM 6  weeks after implantation. 
Margin of a defect: osteoconduction in BBM 
sponge (x40). BBM = Incorporated particle of 
Bovine Bone Mineral, Arrows = Margin of the 
defect.
Fig 2.3b BBM 6  weeks after implantation 
Centre of the same defect as 3a: osteoclasts 
around BBM (x40). BBM = Bovine Bone 
Mineral, Arrows = Active osteoclasts 
around non-incorporated BBM particle.
Fig 2.4 Undecalcified section of cancellous 
bone graft 1 2  weeks after transplantation. 
Labelling reflecting a high remodelling activity. 
The original spongeous structure can be 
recognized (x25).
Fig 2.5 Undecalcified section of cortical 
bone graft 1 2  weeks after transplantation. 
More regular labelling pattern with 
concentric circles over the whole graft 
reflecting a slow remodelling process. Mark 
the difference with fig. 2.4 (x25).
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Fig 2.6 BBM 12 weeks after implantation. 
Extensive osteoclastic activity around remnants 
of non-integrated, partly degraded BBM in the 
centre of the defect (x25). BBM = Bovine Bone 
Mineral, Arrows = Osteoclasts, B = Bone
Fig 2.7 Control defect 24 weeks after 
operation. The non-bridged defect showed 
variable amounts of bone deposition, 
extending to a considerable distance of the 
margins. Remaining osteoblasts or lining 
cells on the bone surface indicated a stable 
phase (x5). N  = Nasal side, P  = Periosteal 
side, B = Bony margin of the defect
39
Chapter 2
2.3.3 Histologic analyses
2.3.3.1 General features
In general no inflam m atory activity, granulation tissue or encapsulation was 
observed in any o f the specimens. The approxim ated periosteal flap and sinus 
epithelium  seem ed thicker over the defects. Pronounced subperiosteal bone 
deposition was observed close to the lesions. These phenom ena could not be seen at 
the side o f  the sinus.
2.3.3.2 Three weeks after transplantation
C ontro l: Bone form ation was seen at the edge o f the defect and m any osteoblasts 
covered the bone, suggesting continuing bone deposition. Thick bands o f 
tetracycline labelled bone indicated an active bone ingrow th in the first period. 
C ancellous an d  co rtica l g rafts: For the first 3 weeks following transplantation, 
cancellous and cortical grafts underw ent com parable repair processes and showed 
com parable revascularisation o f the grafts. N ecrotic tissue in the m arrow  spaces in 
the centre o f  the transplants seem ed to be rem oved by  m acrophages. Local 
osteoclastic activity was seen. Tetracycline was deposited at the edge o f the grafts, 
in sm aller amounts in the cortical than in cancellous grafts. BBM : W oven bone was 
deposited at the edge o f the defect growing centripetally into the porosity  o f  the 
BBM. Spaces w ithout ingrowing bone were infiltrated by  loose im m ature fibrous 
connective tissue.
2.3.3.3 Six weeks after transplantation
C ontro l: C entripetal bony ingrow th labelled w ith thick bands o f  tetracycline and 
thinner bands o f  calcein indicate continuing but slower bone deposition in the w eek 
prior to death. C ancellous: M em branous bone form ation is found at the periosteal 
side o f  the bone graft while at the side o f  the sinus bone deposition and resorptive 
fields could be seen. Bone rem odelling took place throughout the whole graft. No 
tetracycline labelling and a thick area o f  calcein labelling was seen. C ortical: 
subperiosteal and some subm ucosal bone form ation over the donor-acceptor 
transition confirm ed the acceptation o f  the bone graft. The graft itse lf appeared to 
be vital at the m argins and rem odelling took place by  osteoclastic resorption o f the 
bone and bone deposition w ithin the central canals o f  osteons. There was no distinct 
tetracycline or calcein labelling in the centre o f  the graft. BBM : Fan-wise 
centripetal cancellous bone ingrow th in the BBM  sponge em anated m ostly from  the 
m argins o f  the defect (fig 2.3 a) and in the centre o f  the defect an extensive activity 
o f  m ultinucleated osteoclast-like cells was seen around the BBM  (fig 2.3b). A
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Fig 2.8 BBM 24 weeks after implantation.
Integrated BBM near the margin of a defect. No 
remodelling activity is seen around these particles.
(x25). Arrows = Bovine Bone Mineral
sheath o f  fibrous tissue separated the BBM  from  the new  bone in m ost cases. A  few 
BBM  particles w ere incorporated in new ly form ed bone and had becom e part o f  the 
rem odelling process.
2.3.3.4 Twelve weeks after transplantation
C ontro l: Osteogenesis in the control defects was confined to their margins. The 
periosteum  and the underlining paranasal m ucosa w as fused and included some 
isolated islands o f  young bone. The m argins o f  the new  bone were rounded and 
covered w ith fibrous tissue and some osteoblastic cells. The centripetal bone 
ingrow th was labelled w ith xylenol and calcein. The tetracycline labelled bone was 
already rem odelled. C ancellous: H igh osteoblastic activity and some osteoclasts 
revealed activation o f  bone deposition on the graft. In fluorescence m icroscopy all 3 
labels cou ld  be seen  in  an irreg u la r p a tte rn  (fig  2 .4). C o r tic a l:  L am ella r bone 
deposition was seen at the periosteal surface w ith a m arked transition o f 
donor/acceptor bone. The whole graft was involved in the rem odelling process. 
Osteoblasts deposited osteoid w ithin the central canals o f  osteons and areas o f 
necrotic graft m atrix were tunnelled by  new  osteons. A ll three labels were 
recognized over the whole graft, often in concentric circles (fig 2.5). BBM : In 
contrast to the control defects, the BBM  prevented fusion o f the periosteum  and the 
paranasal mucosa. It created an area filled w ith loose connective tissue and 
rem nants o f  BBM. Periosteum , paranasal m ucosa and the m argins o f  the defect 
delineated this area. A t the margins, BBM  was integrated in bone, w hich was lined 
w ith resting osteoblasts and some osteoclasts. A ll three labels were found in the 
bone. In the central area vascular connective tissue appeared m ore m ature and an 
extensive bone resorption was found around rem nants o f  non-integrated, partly 
degraded BBM  (fig 2.6).
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2.3.3.4 Twenty-four weeks after transplantation
C ontro l: The non-bridged defects showed variable am ounts o f  bone deposition, 
often extending to a considerable distance o f  the margins. Resting osteoblasts or 
lining cells on the bone surface indicated a stable phase in w hich only internal 
rem odelling took place as was also indicated by the calcein labelling (fig 2.7). 
C ancellous: The cancellous grafts had a m ore cortical aspect than the original 
spongiosa but not the same as the acceptor bone. The grafts were com pletely 
integrated w ith norm al rem odelling o f  the cancellous bone and cortical bone 
deposition. N o tetracycline, some rem nants o f  xylenol and an equal distribution o f 
calceine labelling could be detected over the w hole graft. C ortica l: Cortical grafts 
had returned to their original structure showing com pact bone. N o areas o f 
tetracycline labelling could be detected. Xylenol and calcein labelling, however, 
were evident. BBM : Integrated BBM  particles could only be detected near the 
original m argins o f  the defect (fig 2.8). The m ajority o f  the particles in  the centre 
appeared progressively to be resorbed and they w ere replaced by  fibrous tissue. 
Only few  rem nants were still present. Thin xylenol and calcein bands and no 
tetracycline labelling were found in the new ly form ed bone around the BBM  
scaffold.
2.4 DISCUSSION
The purpose o f this study was to investigate the feasibility o f  autogenous bone 
grafts and grafts o f  xenogenous anorganic resorbable bone m ineral in osseous 
defects in the m axillofacial area overlying a (para)nasal mucosa. The rationale for 
this approach was that calvarial defects m ay show other responses than 
m axillofacial defects (MAYER et al. 1996).
Three weeks after im plantation the only difference betw een cancellous and 
cortical grafts was an initial faster revascularisation and bone deposition in  the 
former. A fter 6 weeks, the first deposited bone in cancellous grafts is already 
rem odelled, w hile in cortical grafts the first deposited bone is still present. Also 
after 12 weeks rem odelling in the cancellous grafts is more active than in the 
cortical grafts. A fter 24 weeks, the cortical grafts still showed slow rem odelling 
w hile the cancellous grafts had a m ore stable aspect. These differences confirm  the 
faster revascularisation and rem odelling o f  the cancellous grafts (BURCHARDT and 
En n e k in g  1978, A r d en  and Bu rg io  1992).
In case o f  a shortage o f  autogenous bone, it is interesting to know  w hether 
anorganic xenogenous BBM  can be used as an alternative. This question has still to 
be answered. A t the one hand, reports indicate structural sim ilarity to cancellous
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bone and successful and efficient applications in oral and maxillofacial surgery 
(Boyne 1990, Hislop et al. 1993, Wetzel et al. 1995), but at the other hand also 
failures are reported (HISLOP et al. 1993, STASSEN et al. 1994). Bio-Oss® is a BBM 
which closely parallels the structure of human bone enabling an early and effective 
bone apposition (SCHENK 1991, KLINGE et al. 1992) by osteoconduction (FUKUTA 
et al. 1992, KATTHAGEN 1993, JENSSEN et al. 1996). KLINGE et al. concluded from 
their comparison of Bio-Oss® with two synthetic dense non-resorbable 
hydroxyapatite granules in calvarial defects of rabbits, that no tendency of bone 
induction by the BBM was detectable, although the resorbable implant seemed to 
promote initial bone healing more extensively (KLINGE et al. 1992).
In this study centripetal ingrowth of new woven bone in the BBM was seen 
after 3 weeks and the situation was stabilised after 6 weeks. Slow resorption of 
integrated BBM is in accordance with the results of JENSEN et al. (1996). 
Fibroblasts which had migrated to the centre of BBM implanted defects may inhibit 
osteogenesis (NYMAN et al. 1982, GOTTLOW et al. 1984, DAHLIN et al. 1994, Petit 
and RIPAMONTI 1994) by producing factors that hamper differentiation of 
osteoprogenitor cell populations (OGISO et al. 1989).
In a rabbit calvarial wound model THALLER et al. (1993) did not see 
osteoclastic activity 12 weeks after implantation of BBM but they found a 
continuing reactive bone formation. KLINGE et al. (1992), also working in rabbit 
calvaria, found osteoclasts in moderate amounts only close to the BBM implant 
tissue interface indicating an active remodelling but not around the non-integrated 
isolated BBM. This study shows active, ongoing resorption of non-integrated, non­
functional BBM by multinucleated osteoclastlike cells. The same is reported by 
GLOWACKI et al. (1988), who consider this a normal physiological response. These 
results indicate that for answering questions on osseous wound repair in 
maxillofacial regions in relation to (para)nasal mucosa an experimental model as 
used in the present study is more favourable than a model using calvarial defects.
2.5 CONCLUSION
Osseous defects over (para)nasal sinuses filled with autogenous bone grafts, show 
acceptance and incorporation of the graft and heal equivalent to calvarial defects. 
Bio-Oss®, as a BBM, is only osteoconductive, and new bone is formed only at the 
margins of the defect like in non-filled control sites. The bone in the BBM defects is 
only partly in direct contact with the implant surface. Multinucleated osteoclastlike 
cells has gradually resorbed the non-functional, central part of the BBM.
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ABSTRACT
The purpose o f  this study was to compare the regenerative response o f autogenous 
cortical and cancellous bone chips and a natural particulate bovine bone mineral 
(BBM) (Bio-Oss®, Geistlich-Pharma, W olhusen, Switzerland) in standard bony 
defects related to a paranasal sinus together and to bone blocks.
On 13 skeletally m ature fem ale goats four standard critically size full thickness 
bone defects were m ade in the frontal bone overlying the frontal sinus. These 
defects were filled at random  with cortical bone chips, cancellous bone chips, 
spongiosa granules o f  a BBM  or left empty. Fluorochrom e bone m arkers were 
injected subcutaneously 1 and 5 weeks after transplantation and one w eek before 
the animals were sacrificed. The animals were put dow n 3, 6, 12 and 24 weeks after 
surgery.
Particulate autogenous cancellous bone is the m aterial o f  choice for bridging a bony 
defect in the maxillofacial area w hen there is no need for mechanical strength. It heals 
in the same w ay as a cancellous bone block will do. Particulate cortical bone is not 
reliable enough to be used as a solitary bone grafting material under these conditions. 
A  cortical block as a solitary im plant gives better results. Particulate BBM  as a 
solitary im plant in  a critical size defect does not stimulate osteoconduction but gives 
rise to an extensive osteoclastic activity stimulated by the mutual loose relation. A 
solid block o f BBM  is, in a similar case, more reliable.
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3.1 INTRODUCTION
The problem  o f reconstruction o f bony defects in  the maxillofacial region as a result 
o f malformation, infection, trauma, or oncologic resection has not yet been 
satisfactory solved (REDONDO et al. 1995). The survival o f  bone grafts is determined 
partly by the degree and rapidity o f the revascularisation (FONSECA et al. 1980). The 
revascularisation in turn is influenced by the architecture o f  the graft itself. Particulate 
bone grafts present few er barriers to the diffusion o f tissue fluids as well as to the 
subsequent ingrowth o f  vascular tissue o f the host.
Bone chips or particulate bone are easily and conveniently obtained as 
surplus m aterial w hen producing m ajor grafts or perform ing osteotomies (ISAKSSON
1992). It can be used to fill small defects, to correct m inim al contour irregularities 
and for packing around larger grafts. Particulate bone im plants m ay facilitate and 
promote bony regeneration (HABAL 1992b).
W hen there is no surplus material o f  autogenous bone, a second surgical side 
has to be created and the operation time is increased. Therefore alloplastic materials 
have been developed and tested as possible substitutes (REDONDO et al. 1995). In this 
respect deproteinized bovine bone m ineral (BBM ) is supposed to offer excellent 
biocom patibility and physicochem ical characteristics corresponding to the mineral 
component o f the original bone (JARCHO 1981). Bio-Oss® (Geistlich-Pharma, 
W olhusen, Switzerland) is such a natural material consisting o f anorganic bovine 
bone containing carbonate apatite. Investigations have shown Bio-Oss® to have a 
natural morphologic structure, a chemical composition identical to that o f  bone, a 
large inner surface and porosity comparable to that o f  bone, a crystalline structure 
identical to that o f  bone tissue, and a composition that is purely anorganic (THALLER 
et al. 1993, PEETZ 1997).
A  suitable bone substitute is o f interest to reconstructive surgeons: it would 
obviate the need for harvesting autogenous bone with the concomitant risks and costs 
associated w ith a second operative site (DERSOT et al. 1995). Before such materials 
can be used clinically, they have to be tested in animal models. M any o f these tests 
are perform ed in animal calvaria (GLOWACKI et al. 1981, R eid et al. 1981, TAKAGI 
and URIST 1982, ISAKSSON 1992, KLINGE et al. 1992). Calvarial defect models, 
however, m ay show other responses to therapeutic interventions than maxillofacial 
surgical models (MAYER et al. 1996, M erkx  et al. 1999). It is well know n that the 
dura and periosteum  have an osteogenic potential in  young hum ans and animals 
(R eid et al. 1981, Guzel  et al. 1995). In osseous maxillofacial defects how ever the 
(para)nasal respiratory epithelium is involved w hich has an osteoclastic potential. In 
calvarial m orphogenesis and bone healing the dura plays a central role (HOBAR et al.
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1993, Guzel et al. 1995, HOBAR et al. 1996, Yu et al. 1997). In the facial skeleton, 
however, not dura but respiratory epithelium is involved in the morphogenesis. In 
maxillofacial surgery bone grafts are usually used to bridge gaps overlying a 
paranasal sinus with respiratory epithelium as underlining. This respiratory 
epithelium normally acts as a resorptive endosteum, leading to an increase in overall 
size of the (para)nasal sinuses (ZINS et al. 1994).
We have previously evaluated the incorporation of three types of block 
implants (autogenic cancellous, autogenic cortical and a commercially available 
xenogenic BBM (Bio-Oss®)) in osseous maxillofacial defects overlying a paranasal 
sinus in a goat model (Merkx et al. 1999). That animal model appeared to be a 
valuable tool for answering questions on osseous wound repair in maxillofacial 
regions in relation to (para)nasal mucosa and bone block grafting.
The purpose of this study was to compare the healing response induced by 
particulate cortical and spongeous bone and BBM granules in this test model to one 
another and to bone blocks. From a clinical point of view it is important to know 
whether a graft is reliable in terms of stability and bone quality (ISAKSSON 1992).
3.2 MATERIAL AND METHODS
The study was performed on 13 skeletally mature female Dutch milk goats (Capra 
Hircus Sana) of about 2 years of age and weighing about 60 kg. Briefly, under 
general anaesthesia, with a trephine (inner 0  14 mm), a full thickness 
corticocancellous bone plug was harvested from the anterior iliac crest. In a similar 
way a cortical bone plug was removed without avulsing the mandibular nerve. Both 
bone plugs were cut into chips of 10-15 mm by Tessier bone-mill (Leibinger, 
GmbH, Tuttlingen, Germany) and stored in sterile 0.9% NaCl solution. The third type 
of material used in this study was BBM (Bio-Oss®, Geistlich-Pharma, Wolhusen, 
Switzerland), delivered as spongiosa granules of 1 - 2 mm stored in sterile 0.9% 
NaCl solution as well.
Four full thickness bone defects were made in the frontal bone with a 
trephine (outer 0  14 mm) overlying the frontal sinus, leaving the mucosal lining and 
its fibrous attachment to the inner table around the defect intact (fig 3.1). The defects 
were filled at random with one of the implant materials or left empty. Prior to the 
implant procedure metal bone markers were inserted by the method of BJORK (1955), 
one adjacent to each defect to facilitate orientation at sectioning of histological 
specimens and to improve radiographic evaluation.
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F ig  3.1 Schematic drawing o f  the (prepared) 
skull o f  a goa t with trephine holes over the 
frontal sinus (CHA TELAIN1987)
For the histological study, fluorochrome bone markers were injected 
subcutaneously one w eek (Tetracycline 20 mg/kg), five weeks (Xylenol Orange 90 
mg/kg) after implantation, and one week before the animals were put down (Calceine 
7 mg/kg).
Groups o f three animals were surrendered 3, 6, or 12 weeks and 4 animals 24 
weeks after surgery. Block resection o f the frontal bone was perform ed and all soft 
tissue was stripped. The blocks including the transplantation sites were stored in 4% 
0,1 M  phosphate-buffered formaldehyde for fixation. Contact radiographs were 
obtained by placing the frontal bone specimens paranasal side down on a 5 x  7 cm 
intraoral film (Kodak Ektaspeed).
A fter fixation, the explants were divided into smaller specimens in such a 
way that each experimental site was split into two halves. One ha lf was decalcified in 
20% formic acid and 5% sodium citrate, dehydrated and em bedded in Paraplast® 
(Sherwood M edical, St. Louis, U .S.A.) (WIJDEVELD 1991). From these specimens 
serial sections, 7 ^m  thick, were cut transversally in the m idpart o f the lesion and
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stained w ith haem atoxylin and eosin. Two observers evaluated all sections. The 
healing pattern was analyzed with particular reference to fibrous tissue involvement, 
new  bone formation, graft incorporation, bone m arrow developm ent and bone 
maturation. The other h a lf o f  each defect was em bedded in  PM M A without 
decalcification and 30 ^m  sections were obtained using a Leitz 1600 rotating water- 
cooled diamond saw. These sections rem ained unstained and were evaluated by 
fluorescence microscopy.
3.3 RESULTS
3.3.1 Macroscopical and morphological assessment
All goats tolerated the surgical procedure well, w ithout anesthetic complications or 
sepsis. Healing was uneventful in  all instances w ithout any sign o f local infection or 
wound dehiscences. Palpation o f  the defects in sacrificed animals revealed that at 3 
weeks p.o. trephine rims o f the em pty defects were still marked, and at 6 weeks p.o. 
they were m ore rounded. A t 12 and 24 weeks p.o. a tight sheet closed the trephine 
defect and the edges were hardly palpable. The defects filled w ith autogenous 
cancellous bone chips were difficult to detect after 24 weeks p.o. and bridged w ith a 
rigidly fixed layer o f bone in all animals. The autogenous cortical chips inlays were 
still detectable after 24 weeks p.o. because they were pierced at some places by 
connective tissue strains. A t 3 and 6 weeks the BBM  grafted areas were bridged with 
a sheet o f fibrous tissue. A t the edges some new  bone was form ed and granules o f 
BBM  were centrally located. A t 12 and 24 weeks p.o. how ever in the centre o f  the 
defect, BBM  could hardly be detected in the fibrous tissue.
3.3.2 Radiographic analysis
The original cortical or cancellous radiological structure was still detectable at all 
moments. The control defects showed no healing after 3 weeks but at the edges o f 
some defects new  m ineralized bone was observed at later instances. A fter 3 weeks 
(fig 3.2) the defects treated w ith BBM  were more radiopaque than at 6 weeks. A t 12 
weeks tissue w ithin the defects filled with BBM  was not m ineralized completely 
anymore (fig 3.3) and at 24 weeks the am ount o f mineralized tissue w ithin the defect 
had decreased further, suggesting resorption o f the implant.
3.3.3 Histologic analysis
3.3.3.1 General aspects
No generalized inflam m atory activity, granular tissue or encapsulation was observed 
in  any o f the specimens. The approximated periosteal flap and sinusepithelium over
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de control and BBM  defects seemed thicker than in  the areas grafted with autogenous 
bone. Pronounced subperiosteal bone deposition was observed close to the lesions. 
These phenom ena could not be seen at the site o f  the sinus.
3.3.3.2 Three weeks after transplantation
C ontrol: Bone form ation was seen at the edge o f  the defect and superior to the 
acceptor cortex probably as an effect o f  lifting o f the periosteum. Finger-shape 
ingrowth spicules were lined with active osteoblasts, suggesting a continuing bone 
deposition. Thick bands o f tetracycline labelled bone near the edge o f the defect 
indicated an active bony growth in  the first period. Cancellous: A t the acceptor as 
well as the im plant site new  bone was seen throughout the whole defect, produced by 
a layer o f  active osteoblasts around the grafted particles (fig 3.4). M ultinucleated 
osteoclast-like cells were seen occasionally at the site o f the sinus. M ost o f the 
lacunae in  the particles were empty. The tetracycline labelling was vague and could 
hardly be recognized. The calceine labelling, however, could be seen over the whole 
grafted area in the new  bone as well as in the form er chips. C ortical: More 
osteoclast-like cells around the cortical particles were seen than around the cancellous 
particles, m ainly located at the site o f  the sinus. The tetracycline and calcein labelling 
was evident at the acceptor site and around the chips but were less clear than in the 
cancellous grafted areas. The chips themselves were not stained. BBM : In some 
places at the edge o f the defect new  bone was deposited at the BBM  particles by 
osteoblasts m ostly independent o f  the im plant material. In those areas the BBM  
particles seemed to be pushed forward as by a snowshovel. N o signs o f 
osteoconduction could be recognized. N o labelling was found in  or around the BBM  
granules but a clear calceine labelling was present in  the new ly form ed bone 
originating from  the edges o f the defects.
3.3.3.3 Six weeks after transplantation
C ontrol: Centripetal bony ingrowth labelled with thick bands o f tetracycline and 
thinner bands o f calcein indicated continuing but slower bone deposition in the last 
week. The structure o f  the new  bone adapted to the original acceptor bone w ith a 
large central defect filled w ith fibrous tissue. Cancellous: The cancellous chips were 
still recognizable with fibrous connective tissue in  between. M ost lacunae in  the chips 
were empty, but a few  showed viable osteocytes. Osteoclastic but m ainly osteoblastic 
activity around the chips caused a net bone deposition over the whole grafted area. In 
the undecalcified sections tetracycline and calceine labelled the acceptor site more 
extensively than the new  bone in the grafted area. The chips themselves were vaguely
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stained w ith calcein. C ortical: The cortical chips had a necrotic aspect w ith em pty 
lacunae em bedded in  vital new  bone coming from the acceptor bone as well as from 
new  foci in the centre. This new  bone had a cancellous aspect. In some places 
osteoclasts were seen on the paranasal side. One o f the three defects was bridged with 
a small layer o f  new  bone on the periosteal side. The other two defects were not 
bridged. A  tetracycline and calcein labelling could only be detected at the margins o f 
the defect while a solitary calcein labelling was seen in  the new  bone around the chips 
without staining the chips themselves. BBM : Centripetal deposition o f new  bone was 
found w hich was in contact w ith bone-BBM  in some places. Osteoclastic activity was 
seen around the non-integrated BBM  particles at the periosteal as well as paranasal 
side. The interstitial space between the im planted particles was infiltrated w ith 
immature fibrous connective tissue.
3.3.3.4 Twelve weeks after transplantation
C ontrol: Osteogenesis in  the control defects was confined to the margins o f  the 
defects. In the central area a fusion o f the periosteum  w ith the underlining paranasal 
m ucosa was found w ith some isolated islands o f  young bone in between. The margins 
o f the new  bone were rounded and covered with fibrous tissue and some osteoblastic 
cells. The centripetal bone ingrowth was labeled w ith xylenol and calcein. The 
tetracycline labelled bone had already been remodelled. C ancellous: N ew  bone was 
deposited from the edges o f the defect as well as around the chips. A t the periosteal 
side m ore bone form ation was seen than at the paranasal side. The defects were 
totally filled with chips em bedded in  new  bone. The structure o f  the chips was still 
recognizable in the irregular trabeculae o f  the new  bone (fig 3.5). Only occasional 
osteoclasts and osteoblasts were present. Hardly a difference could be seen between 
the acceptor and donor tissue with no tetracycline, a vague xylenol and a clear 
calceine labelling in and around the chips which becam e part o f  the bony structure. 
C ortical: The irregular trabecular structures o f the chips could be recognized with 
empty lacunae em bedded in  new  w oven bone arising from the acceptor and im plant 
sites. The defects were not totally bridged but areas o f new  bone/chips alternated w ith 
islands o f connective tissue. x y len o l and calcein labels were seen over the whole 
grafted area but not w ithin the chips themselves. BBM : A t the edge o f the defect 
incorporated particles o f  BBM  were involved in  the physiologic remodelling process 
(fig 3.6). The space between periosteum  and m ucosa was filled w ith BBM  particles 
em bedded in a stroma o f fibrous tissue. N o bone deposition was found in that area. 
A bundant osteoclastic activity at the paranasal side around these non-integrated 
particles decreased the am ount o f  im plant material.
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Fig 3.2 Radiograph of a frontal bone specimen,
3 weeks after transplantation, with tantalum 
implants around the defects. 1 = Control, 2 = 
Cancellous bone graft, 3 = BBM sponge, 4 = 
Cortical bone graft
Fig 3.3 Radiograph of a frontal bone specimen, 
1 2  weeks after transplantation, with tantalum 
implants around the defects. 1 = Cortical bone 
graft, 2 = Cancellous bone graft, 3 = Control,
4 = BBM sponge
Fig 3.4 Cancellous particulate bone, 3 weeks 
after implantation, embedded in young bone 
delineated by osteoblasts, (orig. magn. x25)
Fig 3.5 Cancellous bone chips, 12 weeks after 
implantation. The structure of the chips is still 
recognizable in the irregular trabeculae of 
new bone (orig. magn. x25). Arrows = former 
chips with empty lacunae
Fig 3.6 BBM 12 weeks after implantation. 
Incorporated particles of BBM are involved in 
the physiologic remodelling process orig. 
Magn.
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3.3.3.5 Twenty four weeks after transplantation
C ontro l: The non-bridged defects showed variable amounts o f  bone deposition, often 
extending a considerable distance from  the margins. Resting osteoblasts on the 
bonesurface indicated a stable phase in  which only internal remodelling took place as 
indicated by  calcein labelling. Cancellous: A  uniform  remodelling process over the 
whole defect could be seen. The form er spongeous structure o f the chips could hardly 
be recognized. In fluorescence m icroscopy more bone form ation at the periosteal than 
at the paranasal side was seen. Some remnants o f tetracycline were found at the edge 
o f the original defect. In the centre m ainly calceine was equally deposited. C ortical: 
Small non-union areas filled w ith connective tissue were still detectable without 
osteoblastic activity. Collagen fibres piarced the bone in a direction perpendicular to 
the bone surface, and the margins o f these defects showed rounded edges. In the 
undecalcified slides tetracycline labelled bone surrounded the chip-like structure in  
the centre while xylenol and calcein labelling were found throughout the whole 
defect. BBM : Some isolated BBM  particles in the centre o f the defect were left and 
em bedded in fibrous tissue w ith osteoclastic activity at the paranasal side. In 
comparison with 6 and 12 weeks the fibrous tissue was more m ature and the amount 
and size o f  granules had decreased.
3.4 DISCUSSION
Particulate bone is com posed o f small chips and is applied in  areas where no 
mechanical strength is required (DODD et al. 1988, HABAL 1992a). Clinically, chips 
are easier to put in  a bony defect than block implants: the defect should be stented 
well w ithout fitting exactly. Healing takes place as the bony chips become 
incorporated. Rapid revascularisation o f the grafted tissue is followed by 
solidification w hich can w ithstand m echanical forces and weight bearing. In humans, 
this process m ay take m ore than a year to be com pleted (MURPHY et al. 1992, M erkx  
et al. 1997, Peetz  1997, M erk x  et al. 1999). Autogenous cortical bone particles o f 
‘interm ediate’ size have the optimal potential for regeneration o f  bone. Small particle 
grafts (8mm ) were quicker revascularized, showed more osteoclastic activity and 
therefore resorbed m uch quicker and m ore complete than the large particle sized 
grafts (50mm3) (FONSECA et al. 1980). The average particle size o f  10-15 m m 3 used 
in this study can be considered as 'intermediate'. FONSECA (1980) found initial edema 
and inflam m ation only in the large particulate grafts. This study shows similarities 
w ith the latter. On the other hand, 12 weeks postoperatively the structure o f  the 
cancellous particles was hardly distinguishable, which is in  agreement with the small 
particulate areas (FONSECA et al. 1980).
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In this research project the defects filled with autogenous cancellous bone 
chips healed uneventfully. After six weeks the defects were nearly bridged, but the 
trabecular structure of the chips could still be detected. In the defects filled with 
cortical chips, osteoblasts were trying to bridge the spaces between the particles. 
Fibroblasts between the cortical chips produced connective tissue strains 
perpendicular to the defects with an inhibitory effect on bone formation: they 
hampered the osteoblasts in bridging the remaining gaps. The chips themselves had a 
necrotic aspect and were not stained by the labels as abundantly as the cancellous 
chips. In cortical block grafts, at that time, a continuum of centripetal labelling of 
tetracycline and calcein was seen although not equally distributed over the whole 
graft (Merkx et al. 1999). So after 6 weeks particulate cortical bone seems not to be 
such a reliable grafting material as the cortical bone blocks are. The cancellous graft 
areas were bridged and accepted in the physiological remodelling process. This is 
similar to the results of bone-block implantation. The cortical graft areas, however, 
were pierced by bundles of collagen: they were not smoothly bridged. This indicates 
that a steady state had been reached: the defect will not heal any further by itself. This 
was also seen by HOLLINGER (1993) who compared autogenous cortical and 
cancellous particulate allergen antigen free bone.
In case of a shortage of autogenous bone, anorganic xenogenous BBM might 
be a valuable alternative (BOYNE 1990, HISLOP et al. 1993, Peetz 1997). However, 
some failures have been reported as well (STASSEN et al. 1994, Wetzel et al. 1995). 
Bio-Oss® is such a natural material consisting of anorganic bovine bone matrix 
containing carbonate apatite.
Histologically, the BBM-implanted sides underwent initial fibroblastic 
response, with formation of immature connective tissue around the granules. The 
centripetal ingrowth of new woven bone in BBM, seen in a previous study with bone 
block implants (Merkx et al. 1999), could not be seen in the particulate BBM 3 
weeks after implantation. The new bone pushed the granules forward as by a 
'snowshovel' and no signs of osteoconduction were seen. This 'snowshovel' 
phenomenon was also observed in BBM implanted sides overlying erupting 
premolars in beagle dogs (Merkx et al. 1997). The assumption that more time for 
incorporation for the BBM granules may improve the results, cannot be supported. 
To prevent this 'snowshovel' effect, it seems better to implant an exact fitting block 
instead of particulate BBM. It is noteworthy that the present results are in agreement 
with previous findings showing that granular hydroxyapatite failed to initiate bone 
differentiation in heterotopic and orthotopic sites (RIPAMONTI and Reddi 1992, VAN 
EEDEN and RIPAMONTI 1994).
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The local mechanical environm ent has great influence on bone regeneration 
and healing. In areas w ith physiological m echanical loading, bone is rem odelled very 
slowly (SALAMA 1983, KLEIN-NULEND et al. 1993), while in areas w ith more 
mechanical loading bone w ill resorb, bone grafts w ill not incorporate (e.g. over 
erupting teeth (MERKX et al. 1997)) or bone fractures will not heal resulting in a 
pseudoarthrosis (MURPHY et al. 1992). The m ultinucleated giant cells/osteoclasts 
observed around the granules 6 and 12 weeks p.o. is also reported in the block study 
but not that excessively (M erk x  et al. 1999). The mutual loose relation o f the 
granules m ay stimulate these cells m ore and in an earlier stage. The presence o f 
m ultinucleated giant cells around the granules 6 weeks p.o. is also reported by other 
investigators who exam ined the tissue responses to non-resorbable hydroxyapatite 
(HA) granules (DERSOT et al. 1995). They stated that the giant cells generally 
flattened and assumed a non-foreign-body type o f configuration. In this experiment, 
after 24 weeks, osteoclasts/multinuclear giant cells are still observed around the non­
incorporated particles suggesting a continuing resorption. It is reported that 
m acrophages with intracytoplasm ic granular particles can be detected 1 year after an 
augmentation procedure o f  the alveolar ridge in  which non-porous HA had been used 
(DONATH 1988).
3.5 CONCLUSION
In conclusion it m ay be stated that autogenous particulate cancellous bone is the 
choice material for bridging a bony defect in  the maxillofacial area w hen mechanical 
strength is not needed. They heal in the same w ay as cancellous bone blocks do. 
Cortical bone chips are not reliable enough to be used as solitary bone grafting 
material under these conditions. A  cortical block as a solitary im plant gives better 
results. BBM  granules as solitary im plant in a critical size defect do not stimulate 
osteoconduction but give rise to an extensive osteoclastic activity, probably 
stimulated by the mutual loose relation or the continuous m echanical changes. A 
solid block o f BBM  is in  a similar case is m ore reliable but not as good as a cortical 
block.
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ABSTRACT
The purpose o f this study was to evaluate the capacity o f  com posite grafts 
consisting o f  either particulate cancellous or particulate cortical bone and anorganic 
bovine bone m ineral (BBM ) (Bio-Oss®) to induce regeneration in standardized 
bony defects overlying the frontal sinus. Four full thickness bone defects o f  critical 
size were m ade in the frontal bone in each o f 8 skeletally m ature fem ale goats. 
These defects were filled at random  w ith com posite cancellous bone/BBM  grafts or 
com posite cortical bone/BBM  grafts. Control defects were not included but could 
be evaluated using data from  a previous study in  w hich the same experim ental 
setting was used19. Fluorochrom e bone m arkers w ere injected subcutaneously 1 and 
5 weeks after im plantation, and 1 w eek before the animals w ere sacrificed. Two 
animals w ere put down at 3, 6, 12 and 24 weeks after surgery respectively. The 
results were evaluated by  histological means including fluorescence m icroscopy. In 
conclusion, com posite grafts consisting o f autogenous cancellous bone/BBM  
yielded good results, com bining the advantages o f  each m aterial alone and reducing 
the disadvantages o f  each w hen used separately. Critical size defects in the 
m axillofacial area, overlying a paranasal sinus, filled w ith this m aterial heal 
uneventfully w ithin 12 weeks. Com posite grafts consisting o f cortical bone and 
BBM  show less favourable results. These grafts induce osteoclasts, probably by the 
presence o f non-functional BBM , resulting in resorption o f  the cortical bone chips.
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4.1 INTRODUCTION
A ugm entation o f the atrophied m axilla by  sinuslifting or reconstruction o f osseous 
defects in  the m axillofacial skeleton in  contact w ith a paranasal sinus is still a great 
challenge. The use o f  autogenous bone grafts has been the ‘golden standard’ so far 
(HABAL 1992). D isadvantages o f  this procedure are the long operation tim e, the 
creation o f  a donor site and the subsequent m orbidity. Furtherm ore, there is often a 
shortage o f donor bone. Some o f these disadvantages can be overcom e or decreased 
by the use o f  bone substitutes.
Bone substitutes m ay be divided into tw o m ajor categories. One consists o f 
an organic m atrix m ade by  either dem ineralizing xenogenous bone or by  the in  vitro 
construction o f collagenous lattices in  w hich osteoinductive proteins are embedded. 
D em ineralized bone m ay have the risk o f  host pathogen transm ission, inconsistent 
perform ance, lim ited supply and tenuous inductive ability. The use o f  recom binant 
hum an osteoinductive proteins em bedded in  collagenous m atrices are prom ising but 
till now  not registered by  the A m erican Food and Drug Adm inistration.
The other m ajor category consists o f  an inorganic m atrix m ade by  either 
sintering calcium  phosphates such as hydroxyapatite (HA) or by  deproteinizing 
xenogenous bone. Inorganic bone m inerals, i f  used alone, do not show the capacity 
to bridge critical size m axillofacial defects (BOYNE 1991, Merkx et al. 1999a and 
1999b). Com posite bone grafts, consisting o f HA and autogenous corticocancellous 
bone, however, seem to be m ore prom ising according to studies in  cleft alveolus 
cases (HABAL 1991), in preprosthetic surgery (HAERS et al. 1991, CAWOOD et al.
1994, TOLMAN 1995) and in post-oncologic surgical reconstructions (COBB et al.
1990, BOYNE 1992). Com posite grafts w ould com bine the advantages o f  their 
com ponents and m inim ise their disadvantages (HABAL 1991). The prim ary role o f 
anorganic additives w ould be the enhancem ent o f  osteoconduction, during the 
second phase o f bone healing (KENT et al. 1983).
Reports on com posite grafts in  w hich anorganic bovine bone m ineral 
(BBM ) such as Bio-Oss® (G eistlich-Pharm a, W olhusen, Switzerland) is com bined 
with particulate autogenous cortical or cancellous bone are lacking up to now. The 
purpose o f this study was to evaluate the possibilities o f  a BBM  in  com bination 
w ith both kinds o f  autogenous particulate bone in  bridging critical size osseous 
defects in  an experim ental setting.
4.2 MATERIAL AND METHODS
The study was perform ed on 8 skeletally m ature fem ale D utch m ilk goats (Capra 
Hircus Sana) o f about 2 years o f  age and weighing about 60 kg. The surgical
63
Chapter 4
procedures have been described extensively elsew here19. Briefly, under general 
anaesthesia a cancellous bone plug w as harvested from  the anterior iliac crest w ith a 
trephine. In a sim ilar w ay a cortical bone plug was rem oved from  the m andible 
w ithout avulsing the m andibular nerve. Both bone plugs were cut into chips o f 
approxim ately 10-15 m m  by  Tessier bone-m ill (Leibinger, Tuttlingen, Germany) 
(CHIAPASCO and RHONCHI 1994) and m ixed (1:1) w ith a xenogenous anorganic 
bone m ineral (Bio-Oss®, G eistlich-Pharm a, W olhusen, Switzerland), delivered as 
spongiosa granules o f  1-2 m m 3.
Four full thickness bone defects were m ade in the frontal bone w ith a 
trephine (outer diam eter 14 m m ) overlying the frontal sinus, leaving the m ucosal 
lining and its fibrous attachm ent to the inner table around the defect intact (fig 4.1). 
In each anim al the defects w ere filled at random  w ith one o f the two im plant 
materials. Prior to the im plant procedure m etal bone m arkers were inserted (B j ^ rk  
1955), one adjacent to each defect to facilitate orientation at sectioning o f 
histological specim ens and to im prove radiographic evaluation. The periosteum  was 
repositioned and the incision closed w ith resorbable sutures. Control defects were 
not included but data from  previous studies w ith the same experim ental setting were 
used (M e rk x  et al. 1999a and 1999b).
For the histological study, fluorochrom e bone m arkers w ere injected 
subcutaneously 1 w eek (Tetracycline 20 mg/kg), 5 weeks (Xylenol Orange 90 
m g/kg) after im plantation, and 1 w eek before the anim als w ere killed (Calceine 7 
mg/kg).
Groups o f 2 animals were put dow n 3, 6, 12 and 24 weeks after surgery. 
N orm al anaesthetic induction procedures w ere perform ed after w hich a lethal dose 
o f pentobarbitone was administered. B lock resection o f the frontal bone was 
perform ed and all soft tissue was stripped. The blocks including the transplantation 
sites were stored in 4%  0.1 M  phosphate-buffered form aldehyde for fixation. 
Contact radiographs were obtained after placing the frontal bone specim en w ith the 
paranasal side down on a 5x7 cm intraoral film  (Kodak Ektaspeed).
A fter fixation, the explants were divided into sm aller specim ens in such a 
w ay that each experim ental site was split into two halves. One h a lf was decalcified 
in 20%  form ic acid and 5%  sodium  citrate, dehydrated and em bedded in Paraplast® 
(Sherwood M edical, St Louis, M O, USA) (WIJDEVELD et al. 1991). From  these 
specimens serial sections, 7 ^m  thick, were cut transversally in the m idpart o f  the 
lesion and stained w ith haem atoxylin and eosin. Two observers evaluated all 
sections. The healing pattern was analysed w ith particular reference to fibrous tissue 
involvem ent, new  bone formation, graft incorporation, bone m arrow  developm ent
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F ig  4.1 Schematic drawing o f  the (prepared) 
skull o f  a goa t with trephine holes over the 
frontal sinus (CHA TELAIN1987).
and bone m aturation. The other h a lf  o f  each specim en was em bedded in PM M A 
w ithout decalcification and 30 ^m  sections were obtained. These sections rem ained 
unstained and were evaluated by fluorescence m icroscopy.
4.3 RESULTS
4.3.1 Macroscopical and morphological assessment
All goats tolerated the surgical procedure well, w ithout anaesthetic com plications or 
sepsis. Healing was uneventful in all instances w ithout any sign o f  local infection or 
w ound dehiscences. The defects filled w ith com posite cancellous bone/BBM  grafts 
w ere difficult to detect clinically after 12 and 24 weeks postoperatively and they 
w ere bridged w ith a rigidly fixed layer o f  bone in all animals. A t 24 weeks 
postoperatively the com posite cortical bone/BBM  grafts w ere still m anually 
palpable because o f  a rough surface at some places interrupted by persisting 
perforations.
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4.3.2 Radiographic analysis
The radiographs did not reveal major differences between the two types of 
composites after 3 weeks. The original chip structure of the cortical/BBM grafts, 
however, was better recognizable than in the cancellous/BBM grafts. After 6 weeks 
the solitary cortical chips could be recognized while the cancellous/BBM grafts 
were more equally amalgamated. After 12 and finally after 24 weeks the 
cancellous/BBM grafted areas could hardly be recognized anymore. The 
cortical/BBM grafted areas were not totally amalgamated but had some 
radiolucencies over the former defects.
4.3.3 Histologic analysis
General aspects. No generalised inflammatory activity, granular tissue or 
encapsulation was observed in any of the specimens during the experimental period. 
Pronounced subperiosteal bone deposition was observed close to the lesions. This 
phenomenon could not be seen at the paranasal side.
Three weeks after transplantation. Cancellous/BBM grafts: An active 
bone formation was observed at the edges of the defects and from individual 
cancellous bone chips (fig 4.2). New bone was deposited along and around a few 
solitary BBM particles. It is self-evident that this 'integrated/accepted' BBM itself 
had a non-vital necrotic aspect with empty lacunae. Most of the BBM particles 
showed no adjacent bone formation. Multinucleated giant cells were resorbing the 
BBM. Vital staining showed calceine labelling at the edges of the BBM granules 
suggesting some active calcium uptake in the BBM. The calceine labelling of the 
cancellous bone chips was more intense. Cortical/BBM grafts: Bone sprouted 
mainly from the edges of the defect. Osteoclastic activity was found around 
individual cortical and BBM chips (fig 4.3). In cortical chips most of the lacunae 
were empty. No fluorochrome markers were found in these chips whereas the new 
bone at the edges was labelled with calceine.
Six weeks after transplantation. Cancellous/BBM grafts: The defects were 
almost bridged with integrated BBM surrounded by 'multinucleated' cells and 
resorption lacunae throughout the whole defect (fig 4.4). Some BBM particles were 
integrated. They were mainly located under the periosteum or the paranasal mucosa, 
embedded in fibrous tissue and surrounded by multinucleated cells. In vital staining, 
the former cancellous bone chips could be recognized by a lower staining intensity 
in their centre surrounded by a zone of intense calceine labelling covering almost 
the whole defect. The BBM granules were equally vaguely stained by calceine. 
Cortical/BBM grafts: At the edges some integrated BBM granules and necrotic
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Fig 4.2 Cancellous/BBM graft 3 weeks after 
implantation. An active bone formation sprouted 
from solitaire cancellous bone chips. The BBM 
particles are surrounded by multinucleated cells 
(orig. magn. x25), B = Bovine bone mineral; C 
= Cancellous bone chip surrounded by new 
bone; arrow = active bone formation.
Fig 4.3 Cortical/BBM graft 3 weeks after 
implantation. Osteoclastic activity was found 
around individual cortical and BBM chips 
(orig. magn. x25). No new bone formation was 
seen around the original cortical chips. B = 
Bovine bone mineral; C = cortical bone chip; 
arrow = multinucleated cells.
Fig 4.4 Cancellous/BBM graft 6  weeks after 
implantation. Integrated BBM surrounded by 
new bone in which the former cancellous and 
the BBM particles could be recognized (orig. 
magn. x25). B = Bovine bone mineral; arrow 
= former cancellous bone chip.
Fig 4.5 Cortical/BBM graft 6  weeks after 
implantation. In the centre of the defects 
osteoclast-like cells surrounded the cortical 
chips and the BBM granules. No bone 
deposition was seen. (orig. magn. x25). B= 
Bovine bone mineral; arrow = multinucleated 
cells.
Fig 4.6 Cancellous/BBM graft 12 weeks after 
implantation. The BBM particles are integrated 
in more compact bone than in Fig. 4. The 
original structure of the cancellous chips could 
hardly be recognized anymore (orig. Magn. 
x25). B = Bovine bone mineral.
Fig 4.7 Cortical/BBM graft 12 weeks after 
implantation. In all cases BBM granules in the 
central area were embedded in mature fibrous 
tissue surrounded by multinucleated cells (orig. 
magn. x25). B = Bovine bone mineral; F = 
fibrous tissue.
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cortical chips were seen in the newly formed bone without osteoclastic activity. 
Most of the BBM granules were not integrated but embedded in a very dense 
connective tissue stroma. In the centre of the defects osteoclast-like cells 
surrounded these granules (Fig 4.5). No tetracycline or calceine labelling of the 
BBM and the cortical chips was seen over the whole defect whereas at the edges the 
new bone was intensely labelled.
Twelve weeks after transplantation. Cancellous/BBM grafts: All defects 
were bridged with bone showing some osteoblastic and osteoclastic activity. The 
BBM particles were integrated in young bone with a physiological remodelling 
showing resorption lacunae (Fig 4.6) but the quantity of BBM was reduced 
compared to the 3 and 6 weeks defects. The vital staining showed a xylenol and 
calceine labelling throughout the whole defect. Hardly any tetracycline could be 
recognized. Cortical/BBM grafts: None of the defects was totally bridged. In all 
cases BBM granules and some cortical chips in the central area were embedded in 
mature fibrous tissue surrounded by multinucleated cells (Fig. 4.7). The new bone 
formed from the edges of the defects was stained with tetracycline, xylenol and 
calceine.
Twenty four weeks after transplantation. Cancellous/BBM grafts: The 
defects were filled with cancellous bone. The initial edges of the defects could 
hardly be recognized anymore. Some small pieces of BBM were integrated and 
bone remodelling was found throughout the former defect. In vital staining no 
tetracycline, a vague xylenol and normal calceine labelling was seen in which the 
original structure of cancellous chips had disappeared. Cortical/BBM grafts: None 
of the defects was bridged. In the centre of the defects some BBM particles and 
some cortical chips could be seen embedded in mature fibrous connective tissue 
without osteoclastic activity. In vital staining the newly formed bone at the edges of 
the defects showed less xylenol and calceine labelling in comparison to the 
cancellous/BBM grafts. At the edges BBM was faintly stained with xylenol and not 
with tetracycline or calceine.
4.4 DISCUSSION
Autogenous bone grafts from different locations are mainly used in augmentation 
procedures of the atrophied maxilla or in osseous reconstructions in the 
maxillofacial area. Problems with resorption of the autogenous grafts, shortage of 
donor site bone and morbidity of the donor site have led to the search for 
alternatives or additives. One of the alternatives to compensate for shortage of 
donor site bone is the use of alloplastic (synthetic) inorganic materials and
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autogenous particulate corticocancellous or cancellous bone in composite graft- 
implant substrates (HABAL 1991, HAERS et al. 1991, CAWOOD et al. 1994, TOLMAN 
1995). These grafts can lead to a better bone regeneration by enhancement of the 
osteoconduction. HA is used as a porous non-biodegradable ceramic resembling the 
anorganic bone matrix.
Another possibility is the use of a biological anorganic material such as 
Bio-Oss®, which has a bovine origin. This material has a normal osseous structure 
and is prone to normal osteoclastic resorption (PINHOLT et al. 1991, M e r k x  et al. 
1999a and 1999b), although other studies refute this (MANDELKOW et al. 1990, 
STASSEN et al. 1994, SKOGLUND et al. 1997, YOUNG et al. 1999). It is 
osteoconductive and becomes involved in normal bone remodelling in which it is 
replaced by new lamellar bone (BOYNE 1992). It is brittle and lacks the basic 
elasticity of normal bone. This makes it less suitable for use on its own (M e rk x  et 
al. 1999a and 1999b). However, in combination with autogenous bone grafts, it can 
provide an additional stimulus for osteoconduction and as an expander (HABAL
1991). The advantages of this additive as supporting material for the particulate 
autogenous bone should be compared with the advantages of the use of this bone 
graft alone.
A bone/HA ratio varying from 1:1 to 1:2 is recommended, to avoid 
excessive fibrous encapsulation of the HA granules (COBB et al. 1990, T id w e l l
1992). Because there was no information about the ideal ratio for bone/BBM a 1:1 
ratio is used in this study.
The maxillofacial defects used in the present study ( 0  14 mm) were of 
critical size (M e rk x  et al. 1999a), which means that they will not heal 
spontaneously (SCHMITZ and HOLLINGER 1986). This size may resemble the 
magnitude of an osseous defect, e.g. in preprosthetic surgery, in a cleft alveolus or 
an osteotomy gap. In the same experimental setting (M e rk x  et al. 1999a) the 
healing pattern of empty defects were described extensively and therefor not used in 
this experiment as a control.
Cancellous/BBM composite grafted areas in our study showed a stable 
situation after 12 weeks. All the defects were bridged and integrated BBM particles 
had to a large extent been replaced by newly formed bone due to physiological 
remodelling. After 24 weeks the same features were seen, although hardly any 
BBM particles could be seen anymore.
The involvement of implanted autogenous iliac crest bone in normal 
physiological remodelling has recently been reported by BLOMQVIST et al. in an 
osteometric and morphometric analysis of sinus lifting procedures . They described
69
Chapter 4
an active bone rem odelling (deposition and resorption) instead o f only bone 
deposition as soon as one m onth after transplantation. These findings m ay indicate 
that cancellous/BBM  com posite bone graft healing is accom plished w ithin 12 
weeks. Extension o f the follow-up period w ith another 12 weeks does not seem to 
result in  a better bone quality. W hen cancellous chips are im planted w ithout an 
additive the same healing response is seen (M e rk x  et al. 1999b): after 6 weeks the 
defects are nearly bridged with the trabecular structure still detectable w hile after 12 
weeks in a stable rem odelling phase this structure had disappeared.
Cortical/BBM  com posite grafts showed a m ore extensive osteoclastic 
activity around non-vital cortical bone chips com pared to grafts consisting o f 
particulate cortical bone alone (M e rk x  et al. 1999b). This study showed that both at 
12 and 24 weeks after im plantation o f cortical/BBM  grafts none o f the defects was 
bridged, w hile after im plantation o f cortical bone alone in  the same setting only 
small fenestrations w ere found in  the form er defects. M ore osteoid tissue w as seen 
w hen pure cortical chips as a bone grafting m aterial was used (M e rk x  et al. 1999b). 
This difference can be clarified by  the presence o f m ore m ultinucleated cells around 
individual granules and the cortical chips. These cells, directly recruited by  the 
presence o f  BBM , are able to resorb the non-vital cortical chips (GLOWACKI and 
COX 1986).
A nother problem  in bone grafting is the m orbidity o f  the donor site. 
Reduction o f the m orbidity can be achieved by  using a trephine for harvesting 
cancellous bone from  the iliac crest (KALK et al. 1996, LUNDGREN et al. 1997) or 
the tibia plateau (VAN DAMME and M e rk x  1996) instead o f  harvesting a 
corticocancellous bone block from  the iliac crest (BANWART et al. 1995) due to 
leaving m ost o f  the m uscular attachm ent uncom prom ised. The present study 
showed that the com bination o f BBM /cortical chips led to a m ore pronounced 
osteoclastic activity than the com bination o f BBM /cancellous bone. This m eans that 
the cortical com ponents in  particulate cortico-cancellous bone grafts m ay not have a 
positively additive influence and can be omitted, leading to a reduction o f  the donor 
site morbidity.
4.5 CONCLUSION
In conclusion, a com posite graft consisting o f autogenous cancellous bone and 
BBM  is reliable, com bining the advantages o f  each m aterial alone and m inim ising 
the disadvantages o f  each w hen used separately. Critical size defects in the 
m axillofacial area, heal uneventfully w ithin 12 w eeks, w hen filled w ith this 
material. A n additional 12 weeks m ay not yield a better bone quality. Cortical bone
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in a com posite graft at least has no additive value in bone healing, and probably an 
opposite effect is reached by  the resorption o f  the cortical chips by  osteoclasts 
induced by  the presence o f non-functional BBM.
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ABSTRACT
The effect o f im planting autogenous and anorganic xenogenous bone transplants 
into m etabolically active sites w ithin Beagle dog m andibles during perm anent 
prem olar tooth eruption was examined. Ten beagles, 14 weeks old were used. 
Before the onset o f  the radiographic experiments, m etal bone m arkers were placed 
in  the caudal m argin o f the m andible at an age o f 10 weeks. The deciduous first and 
third m olar w ere extracted and their sockets over the second and fourth prem olar 
were im planted w ith autogenous particulate enchondral iliac crest bone, autogenous 
particulate m em branous m andibular body bone, xenogenous anorganic bovine bone 
m ineral (BBM ) spongiosa granules (1-2 m m 3) (Bio-Oss®, Geistlich Pharma, 
Switzerland) or left empty. The third prem olar served as control side. Standardized 
oblique lateral radiographs were m ade once a week. A  num ber o f  co-ordinates o f 
defined points and structures were determ ined by  m eans o f a co-ordinate digitising 
system. The animals were put dow n 4, 10, and 16 weeks after bone transplantation 
for histologic exam ination o f the transplantation sides.
A ll prem olars showed no delay in  eruption or disruption o f crown and root 
developm ent. In histology the BBM  particles w ere not resorbed or integrated in  the 
alveolar bone but pushed forward into the gingiva.
W e have dem onstrated that there is no difference in eruption curve o f the perm anent 
prem olars in  the 4 groups (A NOVA p > 0.5) and that bone transplantation has no 
inhibitory effect on eruption (ANOVA p > 0.3) and crown developm ent o f  the 
underlying perm anent prem olar, but that B io-O ss® has not the same resorbable or 
integrating capability as autogenous bone grafts.
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5.1 INTRODUCTION
Secondary bone grafting of the residual alveolar cleft in patients with cleft lip and 
palate has become a well established procedure with well-accepted advantages 
(Freihofer et al. 1993, KALAAJI et al. 1996). One of these advantages is to 
promote the eruption of the permanent canine into the alveolar defect (WITSENBURG 
and Remmelink 1993). Therefore the bone grafting has to be performed prior to 
permanent canine eruption, at the stage in which this tooth has formed about one 
half to two thirds of its root. Usually, free autogenous bone from the anterior iliac 
crest, the rib or the chin of the mandible is used (WITSENBURG and Remmelink
1993). The age of the patient by that time varies between 8 and 12 years. The bone 
graft stabilises the dento-osseous segments, improves alveolar continuity, decreases 
tooth loss due to periodontal disease, increases alar cartilage support, and allows 
any unerupted teeth in the area to erupt through osseous tissue (WITSENBURG and 
Remmelink 1993). These grafts may be autografts, allografts or xenografts. 
Different sources of autografts for closing palatal defects are described: chin, rib, 
calvarium and ileum. Chin bone is reported to give the best results (Freihofer et 
al. 1993). Advantages of the chin as donor site are reduction of operation time, less 
morbidity, decreased admission time in the hospital and an invisible scar 
(HOPPENREIJS et al. 1992). Also the way of healing is in favour of the use of chin 
bone: intramembranous bone i.e. ectomesenchymal bone maintains more of its 
volume (Smith and ABRAMSON 1974) because of less post-operative resorption 
(ZINS and WHITHAKER 1983, KOOLE et al. 1991). This is probably due to earlier 
vascularization of the transplant (KUSIAK et al. 1985) in comparison with 
enchondral, i.e. mesenchymal, bone transplants.
Bone grafting also has disadvantages, such as the need for surgery at 
another site, extension of surgery time, increased possibility of infection, and other 
complications (HOPPENREIJS et al. 1992, SUGIMOTO et al. 1993). A special 
disadvantage of the chin as donor site is its small volume: if  the cusps of the 
mandibular permanent canines are not yet erupted, the space to take a graft is very 
small (BfeHR and COULON 1996). Damage of these teeth is an unacceptable 
complication. So, if there is a chance of damaging the toothbuds, autografts taken 
from rib, ilium or calvarium are indicated (BORSTLAP et al. 1990, WITSENBURG and 
Freihofer 1990, Cohen et al. 1991, Kortebein et al. 1991, Koole et al. 1991).
Apart from autografts also xenografts taken from different species are 
advocated, but they do not have extensive clinical application in palatal surgery. 
The use of xenografts has the potential to reduce morbidity as harvest of autogenous 
bone is unnecessary. The antigenic potential of xenografts can be diminished or
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elim inated by  chem ical treatm ents. Bio-Oss® (Geistlich-Pharm a, W olhusen, 
Switzerland) is a natural m aterial consisting o f anorganic bovine bone m ineral 
(BBM ) containing carbonate apatite. Electron m icroscopic exam inations have 
shown that its m acro- and m icroconfigurations closely parallel the structure o f 
hum an bone. BBM , which is com m ercially available in  either spongiosa or cortical 
blocks and particles, has been com pletely deproteinized by  m eans o f a proprietary 
extraction process that m akes it free o f  antigenicity. This perm its its im plantation as 
a m atrix that appears to stimulate all norm al physiologic responses closely, 
m im icking the stages o f  bone repair (KLINGE et al. 1992). Previous clinical reports 
have dem onstrated its efficiency in oral and m axillofacial surgery (BOYNE 1990, 
H islo p  et al. 1993, W etzel  et al. 1995).
Before using xenogenous bone transplants in  alveolar clefts m ore has to be 
know n about their effect on tooth eruption. Therefore, their effects on the eruption 
o f perm anent prem olars were studied in  beagle dogs after extraction o f the 
deciduous predecessors. The extraction wounds were filled w ith different 
autogenous and xenogenous bone grafts and the subsequent tooth eruption was 
studied by  radiographical and histological techniques.
5.2 MATERIAL AND METHODS
5.2.1 Surgical procedures
The experim ent was perform ed in  10 fem ale beagle dogs o f 14 weeks old. They 
were housed in  light- and tem perature controlled room s and access to food and 
w ater w as allowed ad libitum. Four experim ental treatm ents (m andibular bone graft, 
iliac bone graft, BBM , sham) were carried out in  the extraction-sockets o f  the 
m andibular m1 and m3, the predecessors o f  the P2 and P4. Treatm ent m odalities 
were in  each dog determ ined by  at random  perm utation. The eruption o f the P3 
served as control.
Prior to the surgical procedures, the animals w ere prem edicated w ith 0.5 ml 
Thalamonal® (fentanyl, 0.05 m g/m l plus droperidol 2.5 m g/m l; Janssen 
Pharm aceutica, Beerse, Belgium ) and 0.5 m l atropine (atropine sulphate 0.5 mg/ml). 
Subsequently, they were anaesthetised w ith an intravenous injection o f 30 mg/kg 
Narcovet® (sodium  pentobarbital 60 m g/m l; Apharm o, Arnhem , The Netherlands). 
A fter intubation, anaesthesia was m aintained w ith Ethrane® (enflurane 15 mg/ml; 
Abott, Am stelveen, The Netherlands). The oral m ucosa and the dentition were 
cleaned w ith chlorhexidinedigluconate 0.1%  in water. In addition, approxim ately 6 
ml Xylocaine® (lidocaine hydrochloride 0.4 m g/m l; A stra Chem icals, Rijswijk, The
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N etherlands) was injected into the vestibular m ucosa to avoid excessive bleeding 
during surgery.
A fter routine aseptic m easures the anterior iliac crest was exposed by  means 
o f a 2-3 cm incision through the skin, subcutaneous tissue and periosteum . W ith a 
dental bur a 0,5-1 cm bone graft was harvested. A  sim ilar procedure was used to 
harvest a bone graft from  the angle o f  the m andible which w as used as a substitute 
for chin bone. The bone grafts were placed in  isotonic saline and finally cut into 
small chips up to about 10 m m 3 by  a bone grinder.
The m1 and m3, the predecessors o f  the P2 and P4, o f  the right and left 
m andible w ere extracted. The extraction sockets w ere filled w ith either autogenous 
iliac crest bone chips, autogenous m andibular bone chips, BBM  spongiosa granules 
(1-2 m m 3) (Bio-Oss®, Geistlich Pharma, Switzerland) or left empty. The m ucosal 
defects were prim ary closed by  a m ucosal flap and sutured w ith a resorbable wire 
(Vicryl 3-0, Ethicon, Norderstedt, Germany). The m 2 was left in place to evaluate 
the norm al eruption pattern o f  its successor, the P3.
A ll animals were m edicated prior to surgery w ith 1 ml o f  A lbipen® 15% 
(am picilline anhydrate 150 m g/m l; M ycopharm , de Bilt, The N etherlands) and 
m aintenance doses o f  1 ml Albipen® LA (am picillin anhydrate 100 mg/ml; 
M ycopharm , de Bilt, The N etherlands) on days 2 and 4 postoperatively. A ll animals 
received a norm al diet after surgery.
5.2.2 Radiographic procedures
Before the start o f  the study, under general anaesthesia, tantalum  im plants (Ole 
Dich, Hvidovre, Denm ark), m easuring 1.2 mm in length and 0.5 mm in w idth were 
inserted as bone m arker in  the m argin o f the m andible deep to the m2, the m3 and 
as far distal as possible (B j ^ r k  1955). This w as done 4 weeks before the extraction 
o f the m1 and m3 at an age o f  10 weeks (fig 5.1). During that period every w eek 
standardized oblique-lateral radiographs o f the right and left halves o f  the m andible 
o f  each dog w ere m ade under general anaesthesia to follow  the norm al eruptive 
movem ents. To that end, the animals were fixed in an especially constructed 
cephalostat (MALTHA 1982) w ith two ear rods and w ith a pin in  the m idsagittal 
plane. For the radiographs Kodak® X -ray speed photo (Kodak N ederland BV, 
Driebergen-Rijsenburg, The N etherlands) was used. Radiographs w ere taken w ith a 
Philips Practic® x -ra y  M achine (Philips N ederland, The Hague, The Netherlands), 
set at 20 m A  and 90 kV, the focus-film  distance being 3.0 m, the object-film  
distance 7 cm becam e loose, a new  one was inserted im m ediately, and the
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Fig 5.1 Radiograph o f the mandible o f dog 7, F ig 5.2 Tracing o f the mandible o f dog 7, at 
at an age o f 10 weeks after insertion o f the an age o f 10 weeks with points digitised with 
tantalum bone markers. an electronic measuring table.
radiographic procedure was repeated.
5.2.3 Radiographic analysis
The definition of tooth eruption used in this study has been restricted to the vertical 
movement because only small mesio-distal movements were observed. Therefore 
the changes in the X-co-ordinates of the tips of the teeth during the eruption were all 
omitted.
For each of the radiographs the points of the 3 metal bone markers and the 
tips of the deciduous m1, m2, m3, P2, P3 and P4 were digitised (fig 5.2). The co­
ordinates of these points were digitised with an electronic measuring table (VAN 
D e r  L in d e n  et al. 1972) with a accuracy of 0.01 mm. Due to the stable metal bone 
markers the x-axis was defined as a straight line through the most distant bone 
markers, and the Y-axis as a straight line perpendicular to the X-axis with the origin 
situated at a defined distance from the most proximal bone marker. The co-ordinate 
system was chosen in such way that all the co-ordinates in the mandible were 
situated in the first quadrant, so they had all positive values (MALTHA 1982). To 
describe the eruption of the premolars, the Y-co-ordinates of each measurement 
were plotted against the age of the animals.
5.2.4 Statistical analysis
The developmental stages for the P3 and the P4 are attained almost simultaneously 
(MALTHA 1982). Therefore the data of the P3 could function as a control for the
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eruption of the P4. The eruption of the P2 had no controlled data. The total vertical 
tooth displacement in the experimental, sham and control groups in the period from 
18-23 weeks is compared, using a one-way analysis of variance (ANOVA).
All recordings were performed twice by the first author resulting in a 
measurement error of 0.007 mm for the bone markers and 0.11 mm for the tips of 
the teeth. Finally the mean of both recordings was used reducing the measurement 
error with V2.
5.2.5 Histological evaluation
The animals were sacrificed for the histological study. One animal 4 weeks, 2 
animals 10 weeks, and 6 animals 16 weeks after surgery. One animal had died 
during the surgical intervention at the beginning of the experiment. The 
animalswere brought under general anaesthesia using 30 mg/kg Narcovet®, after 
which 0.5 mg/kg heparin (Thromboliquine®; Organon Tetnika, Boxtel, The 
Netherlands) was administered. After making the final radiographs a lethal dose of 
Narcovet® was injected intravenously. The thorax of the animals was opened and 
the vascular system was perfused via the arch of the aorta with physiological saline, 
followed by 4% neutral formaldehyde as a fixative. After perfusion the mandibles 
were dissected and immersed in 4% neutral formaldehyde, decalcified in 20% 
formic acid and 5% sodium citrate, dehydrated and embedded in Paraplast® 
(Sherwood Medical, St. Louis, U.S.A.) (WIJDEVELD et al. 1991). Serial mesiodistal 
sections were cut at 7 ^m and stained with haematoxylin and eosin.
5.3 RESULTS
5.3.1 Radiology
The eruption curves of the P2, P3 and P4 in all experimental groups are comparable. 
In first instance the premolar moves slowly in an occlusal direction. At a certain age 
the rate of the movements increases, finally reaching a stable plateau after an abrupt 
slowing down of the vertical movement.
Test sites: Two weeks after transplantation (age 16 weeks), the permanent 
P3 and P4 started to erupt through the bone grafts and they were seen intra-orally at 
21 weeks of age without dysplasia or resorption of the crown (SUGIMOTO et al.
1993) and without difference between P3 and P4 (ANOVA, p > 0.3). The mean 
vertical eruption from 18-23 of age showed no difference between the four experi­
mental groups (ANOVA, p > 0.3) (tab 1). The average vertical eruption in the sham 
group seemed to start 1 week earlier than in the other groups without any statistical 
value (fig 5.3).
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age in w e e k s  ag e  in w e e k s
Fig 5.3 Mean relative vertical tooth F ig 5.4 Mean relative vertical tooth 
displacement o f P4 (experimental and sham displacement o f P2 (experimental and sham 
groups) and P3 (control group) groups)
Table 5.1 Mean vertical displacement (in mm) ± SD from 18 to 23 weeks of age.
P2 P3 P4
Control 6.59 ± 1.47
Sham 5.78 ± 1.38 6.90 ± 1.23
BBM 4.40 ± 0.65 6.36 ± 1.49
Mandible 5.93 ± 1.44 7.40 ± 0.56
Iliac Crest 4.35 ± 0.84 7.50 ± 0.92
L EG EN D
P2: No difference between experimental and sham groups (ANOVA, p  > 0.3)
P4: No difference between experimental, sham and control groups (ANOVA, p  > 0.3) 
P2 < P4 for experimental and sham groups (ANOVA, p  < 0.001)
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The eruption curve of the experimental P2 is not as uniform as the one of the P4, 
probably due to mesio-distal and linguo-buccal movements (fig 5.4). Although the 
vertical movement of the P2 in the period 18-23 weeks is slower than the P3 - P4 
(ANOVA, p < 0.001), the rate of eruption shows no significant differences between 
the four experimental groups (ANOVA, p > 0.3).
Control sites: In these sites resorption of the m2 tooth roots and the 
eruption of the successive permanent P3 started 4 weeks after the beginning of the 
experiment. At an age of 21 weeks, the P3 erupted in the oral cavity and its roots 
were almost completely formed. The eruption lasts to a mean age of 23.1 ± 1.0 
weeks. From that point the tip of the P3 remains stable in nearly all animals.
5.3.1 Histology
Mandibular bone chips: In eighteen-week old beagle dogs (four weeks after 
transplantation) the cortical bone chips had a non-vital aspect with only some 
osteocytes in the lacunae and no signs of inflammation (fig 5.5). The surfaces of the 
grafts occlusal to the erupting tooth were integrated in the normal physiological 
process of resorption. The periodontal ligament was intact with a normal structure 
and orientation of the fibres. At an age of 24 weeks the teeth showed no delay of 
eruption or disruption with an attachment of the functional epithelium on the 
enamel-cement border. The implanted bone grafts were incorporated in the 
developing alveolar bone. After 30 weeks all premolars were erupted to their 
functional level with normal alveolar bone height, intact periodontal ligament, 
normal crown and roots of a normal length. No remnants of bone grafts were seen 
anymore.
Iliac crest bone chips: At an age of 18 weeks (four weeks after 
transplantation) the cancellous iliac crest bone chips were fully incorporated with 
osteons among the whole transplant, without signs of inflammation (fig 5.6). The 
structure and orientation of the parodontal ligament of the erupting tooth was 
normal. Some cartilage remnants, probably from the iliac crest, were seen. The bone 
grafts were integrated in the physiological resorption process occlusal to the 
erupting tooth. At an age of 24 weeks no abnormalities were seen. After 30 weeks 
the premolars had emerged with intact periodontal ligament, crown and roots. 
Remnants of the bone chips were integrated in the alveolar bone.
BBM: The number of BBM granules was reduced at 18 weeks (four weeks 
after transplantation) because connective tissue was lying between particles and 
they were not compressed anymore (fig 5.7 and 5.8). The granules were not yet 
incorporated, lying in the empty alveolus as well as occlusal to the alveolar bone
81
Chapter 5
CBC
Fig 5.5 Photomicrograph o f cortical bone 
chips four weeks after transplantation at an 
age o f 18 weeks showing the non-vital aspect 
o f the bone chips with only some osteocytes in 
the lacunae. (Haematoxylin and Eosin; x40). 
CBC = cortical bone chips, AB = alveolar 
bone
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Fig 5.6 Photomicrograph o f spongious bone 
chips four weeks after transplantation at an 
age o f 18 weeks after transplantation showing 
the incorporated bone chips with osteons 
among them. Arrow indicates remnants o f 
cartilage (Haematoxylin and Eosin; x40). 
SBC = spongious bone chips, O = new osteon
Fig 5.7 Photomicrograph o f BBM particles 
four weeks after transplantation at an age o f 
18 weeks showing the connective tissue layer 
around them without signs o f inflammation. 
Arrow indicates BBM particle (Haematoxylin 
and Eosin; x10). T = tooth, AB = alveolar 
bone
Fig 5.8 Detail o f fig  5.7. Osteoclast-like cells 
surrounding the particles (Haematoxylin and 
Eosin; x40)
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Fig 5.9 Photomicrograph o f BBM particles 
16 weeks after transplantation at an age o f 30 
weeks. Arrow indicates BBM particle 
(Haematoxylin and Eosin; x10). T = tooth, AB 
= alveolar bone
Fig 5.10 Photomicrograph o f one BBM  
particle 16 weeks after transplantation at an 
age o f 30 weeks showing the thin fibrous sheet 
around the particle lying in connective tissue, 
not integrated in the alveolar bone. Arrow  
indicates BBM particle. (Haematoxylin and 
Eosin; x40)
within connective tissue. Macrophages and osteoclast-like cells surrounded them. 
The attachment of the fibres of the periodontal ligament of the erupting tooth had a 
normal height at the enamel-cement border. At 24 weeks foreign body giant cells 
were seen in the vicinity of the particles without further signs of inflammation. The 
presence of the granules was restricted to the connective tissue occlusal to the 
enamel-cement border.
At an age of 30 weeks a thin fibrous sheath without an inflammatory 
response or osteoclastic activity surrounded most of the BBM particles (fig 5.9 and 
5.10). Some of them were incorporated in the bone but most of them sat in 
connective tissue occlusal to the alveolar bone. The premolar eruption was 
undisturbed with a normal structure of the periodontal ligament, crown and roots.
Control: The eruption processes in the control group were not disturbed 
with a normal orientation and structure of the fibres of the periodontal ligament. In 
the period between extraction of the deciduous molar and emergence of its 
successor no alveolar bone was deposited in the empty alveolus.
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5.4 DISCUSSION
There are still unanswered questions to the physiology of bone transplantation into 
the alveolar defect. One of these questions concerns the effect of the bone graft on 
the eruption of the permanent canine. In our institute chin bone, of 
ectomesenchymal origin, is the chosen grafting material (FREIHOFER et al. 1993). 
Membranous bone has several advantages over enchondral bone: it usually is 
removed with less donor site morbidity and less postoperative pain (TESSIER 1982, 
ROCHE and S c h w a r tz  1993, B A h r and COULON 1996) and it has been shown that 
it is less subject to postoperative remodelling and resorption (S m ith  and 
A b ra m s o n  1974, Z in s and W h i th a k e r  1983, F e in b e rg  and V i t t  1988, B A h r 
and COULON 1996). In this experiment there were no indications of a slower 
eruption through the mandibular bone graft. Only the eruption through the 'empty' 
alveolus of the P4 seemed to start earlier than through the grafted alveolus.
Studies of premolar eruption in dogs have shown that it is accomplished 
primarily by localised resorption of alveolar bone on the coronal side of the tooth 
( C a h i l l  1969, M a r k s  and C a h i l l  1986, M a r k s  et al. 1993), that the osteoclasts 
are activated on bone surfaces just prior to eruption (MARKS et al. 1983, W ise et al. 
1985) and that eruption depends on the dental follicle proper, a thin collagenous 
investment of the crown of each developing tooth (CAHILL and MARKS 1980, 
MARKS and C a h i l l  1984, M a r k s  et al. 1993). This cell-mediated process results in 
a local tuning of the erupting tooth and the overlying alveolar bone.
In our experiment the erupting premolars are able to resorb the cancellous 
iliac crest and cortical mandibular bone grafts without any difference to each other 
and to the control sites. The number of BBM granules is reduced, although we did 
not see resorption sites. The presence of osteoclasts on the surface of BBM granules 
at 4 and 10 weeks after surgery as observed by us and KLINGE et al. (1992) only 
suggest resorption in a more physiological manner. Most of the BBM granules are 
pushed forward into the soft tissues or probably discharged into the oral cavity 
during the eruption. Maybe more time for incorporation is needed in comparison 
with autologous bone transplants because of the lack of osteoinductive capacity 
( T h a l l e r  et al. 1994).
The results of our study are in accordance with a study which showed that 
the effect of four kinds of calcium phosphate ceramic particle insertion 
(hydroxyapatite (HA) dense and porous, and tricalciumphosphate (TCP) dense and 
porous) on tooth eruption in 20 3-month old dogs gave no delay of tooth eruption, 
no dysplasia and no resorption of dental hard tissue (SUGIMOTO et al. 1993). Studies 
on the effect of calciumphosphate on tooth eruption in forty 3- to 4-month old
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kittens indicated that the use of a nonresorbable HA for grafting, however, resulted 
in impediment of eruption and distortion of crown development. This was in 
contrast to the TCP, which had a minimal effect on tooth eruption and development 
(F e in b e r g  and V it t  1988, F e in b e r g  et al. 1989). So the uniformity of eruption 
curves in our experimental (and control) groups indicates that BBM may be 
considered as a resorbable calcium phosphate.
5.5 CONCLUSION
The results of this study indicate that the use of cortical mandible bone or 
spongeous iliac crest bone in residual alveolar clefts has no negative influence on 
the eruption of permanent teeth.
The number of BBM particles decreased during eruption. Probably the time 
interval between insertion of the particles and the start of the eruption is too short 
for incorporation into the bone because of the lack of osteoinductive capacity. BBM 
particles separated from new bone are pushed into peripheral soft tissue or 
discharged into the oral cavity at the time of eruption. Iliac crest bone, mandibular 
bone and BBM, when implanted into extraction sockets of deciduous teeth, have no 
inhibitory effect on eruption and crown development of the underlying permanent 
mandibular premolars. Before using this xenogene bone mineral in alveolar clefts, 
more has to be known of the healing process in osseous defects, resembling the 
volume of alveolar clefts.
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ABSTRACT
A variety of anorganic alloplastic grafting materials are used in the oral- and 
maxillofacial (OMF) area to bridge osseous defects or to create adequate bone- 
volume for placement of endosseous implants. Because of the variation in literature 
data about the effectiveness of these materials in reconstructive procedures of the 
maxilla in comparison with autogenous bone grafts, it is difficult to make protocols 
and select proper indications. A literature search in ‘Medline’ from 1989-1999 was 
performed to get a better insight into the pros and cons of the different modalities. 
Studies in which different graft materials were used in contact with the maxillary 
sinus with histomorphometric data were selected. Eight studies met the inclusion 
criteria: in 6 studies bone grafts were used in sinus floor elevation procedures and in 
2 studies osteotomy gaps were bridged. It is concluded that autogenous bone gives 
the highest amount of osteoid volume, independent from the healing interval (1-24 
months), application form (particulate versus block) and donor site (iliac crest 
versus chin). The results of inorganic calcium phosphate materials (bovine bone 
mineral or hydroxyapatite), solitary or as additive in composite grafts with 
autogenous particulate bone or demineralized freeze dried bone, shows a large 
range of values, but in all cases the results are inferior to those of autogenous bone 
grafts. The data on anorganic calcium phosphate materials cannot be compared 
mutually, because of differences in healing interval, mixture ratios and histological 
procedures, but they do indicate that the use of composite grafts is to be preferred 
over the use of solitary anorganic bone mineral.
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6.1 INTRODUCTION
Bone grafting in oral- and maxillofacial (OMF) surgery is a common procedure. 
Well-known indications for osseous reconstructive surgery are the augmentation of 
the floor of the maxillary sinus in the severely atrophic posterior maxilla, the 
reconstruction of the alveolus in cleft palate patients, bridging osteotomy gaps or 
reconstruction of (post) traumatic osseous defects. Various therapeutic protocols, 
surgical techniques, and materials are used. The debate still continues about the best 
graft material and the proper indications and protocols (KENT and BLOCK 1989, 
C h a n a v a z  1990, P e t t i s  et al. 1990, R e ic h e  and G a r k  1991, W a g n e r  1991, 
CRANIN et al. 1993, MOY et al. 1993, VLASSIS et al. 1993, H U r z e le r  et al. 1997). 
Interpretation of literature is hampered by personal preferences of the authors which 
hinders direct comparison of studies concerning human bone grafting in the OMF 
field. Nevertheless such a comparison may be worthwhile for the development of a 
consistent protocol to optimise the success of surgery in the long term. The three­
dimensional form of the defect, the vitality and quality of the (newly formed) bone 
and the subsequent success of implantology, orthodontics, and stability and bone 
continuity dictates the protocol of choice after orthognathic and trauma surgery.
In the past, autografts were the only material of choice for bridging an OMF 
osseous defect (HABAL 1992). Bone substitutes nowadays are commonly used to 
minimise donor site morbidity and to diminish the length of hospitalisation. The 
amount of osteoid in the grafted area is used as an indication of success of the 
procedure. This can be measured by histomorphometric analyses of core biopsies. 
Such evaluation is not possible in orthognathic surgery, trauma cases or bridged 
cleft alveolus, as in these cases a re-entry into the acceptor site has to be avoided 
and thus standardized biopsies are not taken. In preprosthetic surgery, however, 
histologic data can be obtained during implant- or abutment placement after several 
months of graft healing and so information about bone quality can be provided. This 
could be extrapolated to an indication for the success of bone grafting in 
orthognathic-, trauma- and cleft palate surgery, e.g. for the stabilisation of fractures 
and the ability to withstand the stresses induced through mastication.
The majority of the reports on the augmentation of the bony floor of the 
maxillary sinus in humans, have been in the form of clinical reports on implant 
survival over a given period with autogenous bone graft (ABG) from the iliac crest 
(KENT and BLOCK 1989, LOZADA et al. 1993, NYSTROM et al. 1993, RAGHOUBAR 
et al. 1993, CAWOOD et al. 1994, KELLER et al. 1994, MISCH and DIETSH 1994, 
GUNNE et al. 1995, BLOMQVIST et al. 1996, 1998a, CHAN et al. 1996, BLOCK and 
KENT 1997, DAELEMANS et al. 1997, LUNDGREN et al. 1997, 1999, SCHLIEPHAKE et
91
Chapter 6
al. 1997, JENSEN and S e n n e rb y  1998), bone substitutes such as allografts (S m ile r  
et al. 1992, FUGAZZOTTO 1994, VALENTINI and A b e n s u r  1997, JENSEN and 
S e n n e rb y  1998), hydroxy-apatite (HA) (W a g n e r  1991, S m ile r  et al. 1992, 
S m a l l  et al. 1993, F u g a z z o t t o  1994, H ü r z e l e r  et al. 1996, W h e e le r  1996, 
W h e e le r  et al. 1997) and bovine bone mineral (BBM) (S m ile r  et al. 1992, 
HÜRZELER et al. 1996, VALENTINI and ABENSUR 1997) or combinations of different 
kinds of materials ( T id w e l l  et al. 1992, MOY et al. 1993, SMALL et al. 1993, 
H ü r z e l e r  et al. 1996, KAPTEIN et al. 1998).
Evaluations of survival rates only are not indicative for the quality of the 
bone graft ( W h e e le r  et al. 1996, B lo m q v is t  et al. 1998b, T o n g  et al. 1998). For 
the evaluation of bone quality histomorphometric analyses of core biopsies are 
indicated as they enable quantification of bone healing and remodelling. The 
purpose of this paper is to review the literature of histomorphometric data on 
different anorganic grafting materials used in the OMF sinus area in humans in 
comparison to autogenous bone. These data will be compared with data derived 
from animal experiments because these models are in principle accurate and 
reproducible although they will not always completely imitate the human situation. 
A meta-analysis of the literature would be preferable as it offers a structured method 
to systematically identify, review and analyse published reports. However, due to 
variations in experimental set-ups and data reporting, this appeared to be 
impossible.
6.2 LITERATURE SEARCH
Two reviewers (MM, JM) searched Medline from 1989-1999 for literature 
on histological evaluation of bone grafts in sinus, facial, orofacial and maxillofacial 
surgery in human studies in which anorganic matrices such as HA, coral or bovine 
bone mineral (BBM) were used, in the English literature. The reviewers used the 
following criteria: Reports about clinical histomorphometric analysed bone cores 
after sinus floor bone grafting or bridging osteotomy gaps were accepted, despite 
differences in histological techniques. In some instances older literature was 
included in order to clarify the background of choices and decisions reported.
‘One area grafted’ case-reports and papers only concerning the 
osseointegration of dental implants, the quality of the sinus epithelium, or the 
treatment of periodontal defects were excluded. Evaluations of bone grafts or 
substitutes in combination with membranes for guided bone regeneration were also 
excluded. Furthermore clinical studies dealing with the function of osteoinductive 
proteins (BMP’s) in graft healing were not evaluated because they are not admitted
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for clinical use by the American Food and Drug Administration (FDA) and the 
research is (therefore) still in a phase II stadium with unpredictable results 
( G r o e n e v e ld  et al. 1999b).
6.3 CORE PUBLICATIONS
Eight clinical papers reporting on anorganic or autogenous grafting materials in 
contact with the maxillary sinus (6 sinus floor grafts and 2 osteotomy gaps), were 
found in which biopsies, taken before implant or abutment placement, were 
evaluated histomorphometrically (table 6.2) (MOY et al. 1993, NUNES et al. 1996, 
W h e e le r  et al. 1996, A y e rs  et al. 1998, B lo m q v is t  et al. 1998b, L o r e n z e t t i  et 
al. 1998, FROUM et al. 1998, HANISCH et al. 1999). A y e rs  et al. (1998) and N u n e s  
et al. (1996), from the same institute, determined the long-term bone ingrowth into 
and -apposition along HA porous implants placed to bridge osteotomy gaps. 
BLOMQVIST et al. (1998b) tried to determine the importance of bone graft quality 
for implant integration after maxillary sinus reconstruction with iliac ABG. FROUM 
et al. (1998) reported the data of 34 sinus floor elevations that used BBM alone 
(n=5) or in combination with ABG (n=7) or demineralized freeze-dried bone 
allograft (DFDBA) (n=8) or a combination of these three materials (n=14) as a graft 
material. The results of their 79 sinus floor elevations which membranes were used 
for guided bone regeneration are not discussed. HANISCH et al. (1999) evaluated 
mineralization stages and processes during bone healing 6, 8, 10 or 12 months after 
allogenic-xenogenic bone grafting sinus augmentation procedures in 20 patients. 
LORENZETTI (1998) discussed in a ‘preliminary’ report the bone augmentation of 
the inferior floor of the maxillary sinus with ABG (chin block (n=3), chin 
particulate (n=3), iliac crest (n=8)) or a composite (HA/ABG chin) (n=3) bone graft. 
MOY et al. (1993) used histomorphometric analysis to quantitate the bone 
composition of a corticocancellous chin bone block (n=1), HA (n=1), a composite 
of these two materials (1:1) (n=4) and HA mixed with demineralized bone powder 
(n=1) in maxillary sinus augmentation. The single cases will not be discussed. 
W h e e le r  et al. (1996) evaluated the results of 36 sinusfloor augmentations with 
HA (n=16), HA/oral ABG (n=12), HA/iliac crest ABG (n=6), BBM (n=1) and iliac 
crest ABG (n=1). Because case reports were excluded the last two materials are not 
discussed. Several aspects of these papers will be discussed in relation to other 
literature.
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Table 6.1 Histometric evaluated healing intervals in months of grafts implanted in human maxillary sinus.
Literature A yers Blo m q v ist FROUM Ha n isc h LORENZETTI M oy  Nun es W h e ele r
et al. 1998 et al. 1998 et al. 1998 et al. 1999 et al. 1998 et al. 1993 et al. 1997 et al. 1996
Grafting material
A BG chin block 10
A BG chin particulate 4
A BG iliac bone 1, 2, 4, 6, 12 6
BBM 6
BBM /ABG 6
BBM /ABG/DFDBA 6
BBM /DFDBA 6 6, 8, 10, 12
HA 4 - 3 6  [19] 1 4 - 3 0  [19] 6
HA/ABG chin (1:1) 12 6, 10
HA/ABG iliac crest (1:4) 6
HA/ABG oral (4:1) 6
L EG EN D
ABG = Autogenous Bone Graft 
BBM = Bovine Bone Mineral
DFDBA = Demineralized Freeze-Dried Bone Allograft
HA = Hydroxyapatite
DBP = Demineralized Bone Powder
n = Months
Table 6.3 Osteoid volume in % of total field after sinus floor elevation procedures.
Grafting material 
Versus time
Standard 1 mns 2 mns 4 mns 6 mns 8 mns 10 mns 12-24 mns n Author
A BG chin block 69.3 3 LORENZETU et al. 1998
A BG chin particulate 62.6 3 LORENZETU et al. 1998
A BG iliac bone 53.0 8 LORENZETU et al. 1998
A BG iliac bone 41 23 38 33 26 4, 5, 6, 4, 2 Blo m q v ist  et al. 1998
A lveolar ridge residual 32.6 17 Ha n isc h  et al. 1999
BBM 8.5 5 FROUM et al. 1998
BBM /ABG 18.5 7 FROUM et al. 1998
BBM /ABG/DFDBA 19 14 FROUM et al. 1998
BBM /DFDBA 14 8 FROUM et al. 1998
BBM /DFDBA 8.1 9.0 11.8 20.7 5, 5, 5, 5 Ha n isc h  et al. 1999
HA 16.4 16 W h eeler  et al. 1996
HA 27 8 NUNES et al. 1997
HA 23 17 AYERS et al. 1998
HA/ABG chin (1:1) 43.6 3 LORENZETTI et al. 1998
HA/ABG chin (1:1) 44.4 4 MOY et al. 1993
H A/A BG iliac crest (1:4) 19.3 6 W h eeler  et al. 1996
HA/ABG oral (4:1) 11.3 12 W h eeler  et al. 1996
LEGEND
ABG = Autogenous Bone Graft 
BBM = Bovine Bone Mineral
DFDBA = Demineralized Freeze-Dried Bone Allograft
HA = Hydroxyapatite
DBP = Demineralized Bone Powder
n = number of grafted sinuses in each group
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6.3.1 Histology
Evaluation of the core literature is hampered by the variation in histological 
techniques used. Histomorphometrical evaluation of bone is performed in most 
cases by some kind of grid method. In this method a grid is placed over the 
microscopical image. By counting the number of points or measuring the length of 
the lines that overlie the item of interest, the volume of that item can be estimated. 
The value of bone histomorphometry is dependent on impeccable tissue 
preservation and proper section thickness. The effect of tissue thickness refers to an 
increase in the visualisation of tissue compartments as section thickness increases 
(HOLMES and ROSER 1987). In general, as the specimen thickness is increased, the 
accuracy of the histomorphometric assessment decreases. The optimal thickness of 
specimen is 4.5 -  5 ^m (JOWSEY 1977). Another method of quantitative analysis 
used the backscattering scanning electron microscopy. This technique does not 
depend on sectioning of the tissue (HOLMES and ROSER 1987). Both techniques are 
used in the core articles (table 6.2). In 3 papers 30-45 ^m histologic sections were 
used (MOY et al. 1993, W h e e le r  et al. 1996, FROUM et al. 1998), while in the 
other studies 10-20 ^m (HANISCH et al. 1999), 7 ^m (LORENZETTI et al. 1998) or 4 
^m (BLOMQVIST et al. 1998b) section thickness was used. In the studies in which 
HA bone grafts were placed to bridge osteotomy gaps, 400 ^m sections were 
ground (N u n es  et al. 1997, A y e rs  et al. 1998). In spite of these differences and 
because of the absence of other, more uniform literature, we put these data together 
knowing the results are only indicative without secure value.
The amount of osteoid from the residual alveolar process, which has been 
undisturbed during the grafting procedure as measured by Hanisch et al. (1999), 
was 32.6%. This datum was used as an internal standard. The values in table 6.3 can 
be related to this standard as far as measurements with the backscatter method are 
concerned (table 6.2). This can give an indication of the vitality of different grafting 
materials used in clinical sinus floor elevation procedures. Because of the difference 
in patient numbers and time intervals between implantation and biopsy, no definite 
conclusion can be drawn. Most data are available at a six months healing time 
interval. Histomorphometric analyses of ABG in the core publications gave the 
highest amount of bone content in the grafted area (23.0% - 69.3%) independent of 
the interval used for healing. No clear difference could be detected between 
different donor sites and application forms (chin versus iliac crest or block versus 
particulate). The histomorphometric values of composite grafts consisting of ABG 
and an anorganic mineral (HA or BBM) showed no difference in the amount of 
bone in the grafted area (11.3% - 19%), whereas HA alone (16.4% - 20.3%)
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differed slightly from BBM alone (8.5%) (table 6.3). All composite grafts have a 
lower osteoid content (8.1% -  19.3%) than the residual alveolar ridge (32.6%). The 
histomorphometric data in the core studies on composites also have a lower osteoid 
content than ABG. It seems that ABG’s are in favour to composites as they show at 
least temporarily a higher osteoid content than the residual alveolar ridge.
In animal studies in which grafts consisting of cancellous ABG/BBM (1:1) 
were used. Good results were obtained, combining the advantages of each material 
alone and reducing the disadvantages of each when used separately (M e rk x  et al. 
2000).
Table 6.2 Techniques used for histomorphometric analyses in core papers.
A u th o r Y ear Slide T hickness (^.m) H istom orphom etric  T echnique
Ayers et al. 1998 400 - grinding Histomorphometry
BLOMQVIST et al. 1998 4 Histomorphometry
FROUM et al. 1998 35-45 Histomorphometry (computerized)
Hanisch et al. 1999 10-20 Backscatter electron microscopy
LORENZETTI et al. 1998 7 Histomorphometry
MOY et al. 1993 30-40 Backscatter electron microscopy
NUNES et al. 1997 400 - grinding Histomorphometry
Wheeler et al. 1996 30-40 Backscatter electron microscopy
6.3.2 Healing period
Another problem in the evaluation of the core publications is the difference of time 
interval between bone grafting and biopsy taken between the studies and sometimes 
even during a research project. For example, LORENZETTI et al. (1998) evaluated the 
bone quality after sinus elevation procedures of four different grafting materials 
(iliac crest bone blocks, chin bone blocks, particulate chin bone and composite 
chin/HA (1:1)). The ‘iliac crest bone’ group was biopted after a 6 months’ healing 
period “to limit the graft volume resorption that has been reported with iliac crest 
bone grafts” (S m ith  and A b ra m s o n  1974, B u r c h a r d t  1987, N y s t r o m  et al. 
1995). The ‘chin bone block’ group was biopted after 8-12 months “to achieve 
sufficient revascularization and viability of this type of graft, essentially consisting 
of compact bone” (URIST 1980, BURCHARDT 1987). The ‘particulate chin bone’ 
group was biopted after 4 months, “since the original compact bone structure had 
been removed by the particulation process and graft volume could be presumed to 
occur during the first phase of healing” (SHIROTA et al. 1996). The healing for the
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fourth group (chin ABG/HA (1:1)) was prolonged to 12 months to “allow adequate 
new bone formation, as indicated for this type of graft” (MOY et al. 1993).
Only two prospective studies evaluated the mineralization stage with the 
same grafting material at various time intervals (BLOMQVIST et al. 1998b, HANISCH 
et al. 1999). HANISCH et al. (1999) used BBM/DFDBA and evaluated it after 6, 8, 
10 and 12 months. In their study no statistically significant difference was seen 
between the amount of newly formed bone in the grafted areas during the different 
intervals was seen. They concluded that the mineralization process of this 
composite is already complete after six months, but new bone formation continues 
at least up to 12 months resulting in a higher osteoid content (table 6.3). At that 
time, however, the amount of newly formed bone was still lower than the volume of 
residual bone. BLOMQVIST et al. (1998b) reported a highly increased bone 
remodelling (deposition and resorption) activity already 2 months after grafting and 
concluded that an extension of the healing period by an additional 2 or 4 months 
would not yield any advantage but may rather induce progressive bone resorption.
In other human and animal studies different measures were used for healing 
capacity and also time scales differed (LUNDGREN et al. 1999). In some human 
studies it appears that a period of six or even twelve months is too short to allow 
complete incorporation of the bone graft (NYSTROM et al. 1993; A y e rs  et al. 1998). 
When HA is implanted solitarily, the amount of bone present within the implant 
increases with implantation time and appears to reach a plateau around the 20 
months time frame (A y e rs  et al. 1998). In course of time the soft tissue gave way 
to primarily woven and lamellar bone. If cancellous chips, with or without an 
anorganic additive, are implanted in a frontal sinus wall defect of goats, bone graft 
ingrowth is accomplished within 12 weeks (MERKX et al. 1999b, 2000). Extension 
of the follow-up period with another 12 weeks did not seem to result in a better 
bone quality. This kind of studies revealed that new bone formation in grafts in 
contact with the maxillary sinus varies considerably depending on bone graft type 
and healing time.
6.3.3 Materials
Twelve different (combinations of) materials are used in the core publications and 
evaluated at different time intervals (1-24 months) (table 6.1). The only anorganic 
bone substitutes used in the core studies are BBM and HA. Their action is based on 
osteoconduction, which means that new bone formation takes place along their 
surface. In one study also DFDBA is used in composites. DFDBA may result in 
both osteoinduction and osteoconduction (MISCH and DIETSH 1993), although the
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inductive capacity is disputable (GROENEVELD et al. 1999). It is generally believed 
that BMP’s and other non-collagenous proteins in the matrix are responsible for the 
osteoinduction of this material (Z h a n g  et al. 1997).
Particulate bone material is easily and conveniently obtained as a surplus 
material when harvesting major grafts or during osteotomies. It may be used to fill 
small defects, to correct minimal contour irregularities and for packing around larger 
grafts. Also particulate bone can easily be mixed with anorganic bone additives. 
LORENZETTI et al. (1998) evaluated the differences in behaviour of blocks versus 
particulate materials. They suggest that graft architecture, conformation, and 
composition may influence the mean bone content at the end of the healing. In an 
animal study it was stated that autogenous cancellous bone chips are the material of 
choice for bridging a bony defect in the maxillofacial area when there is no need for 
mechanical strength. They heal in the same way as cancellous bone blocks do and are 
easily and conveniently obtained as surplus material when producing major grafts or 
performing osteotomies (MERKX et al. 1999a, b).
The combination of an anorganic bone mineral with autogenous bone 
grafts, can provide an additional stimulus for osteoconduction and as an expander 
(HABAL 1991, LINDHOLM et al. 1994). The ideal composite ratio is still unknown, 
as no research has pointed out this parameter in detail. However, the different ratios 
of composite mixtures may be of influence on the results. An ABG/HA ratio 
varying from 1:1 to 1:2 is recommended to avoid excessive fibrous encapsulation of 
the hydroxyapatite granules (COBB et al. 1990; TIDWELL et al. 1992). In one of the 
core papers the mixture rates differed: W h e e le r  et al. (1996) said there “usually 
was a mixture of 4:1 ratio of HA to autogenous intraoral bone whereas the reverse 
was true when using bone harvested from the iliac crest”. An argument for this 
difference is not given. When the ratio of anorganic bone mineral versus ABG 
increased, the radiological evaluation showed that resorption of the bone additive 
decrease exponentially (HORCH and STEEGMANN 1985).
In an animal histological study it is shown that cancellous ABG/BBM (1:1) 
composite grafted in frontal sinus wall defects showed a stable situation after 12 
weeks and that the BBM particles had become replaced to a large extent by newly 
formed bone due to physiological remodelling. After 24 weeks the same features 
were seen, but BBM particles could hardly be detected anymore (MERKX et al. 
2000).
DFDBA showed lower osteoid contents after 6 months than the autogenous 
grafts (FROUM et al. 1998, HANISCH et al. 1999). It was observed that formation of
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mature lamellar bone in these kinds of grafts took at least twice as much time as in 
autogenous bone grafts (JENSEN and S e n n e rb y  1998).
Two differences between HA and BBM may be important for the clinician. 
First, the three-dimensional structure, including the porosity of the grafting 
material, which has an important effect on bone healing (HOLMES 1987, KASPERK 
et al. 1988, DACULSI and PASSUTI 1990, VAN EEDEN and RIPAMONTI 1994, 
HÄMMERLE et al. 1997). Materials exhibiting large surface areas showed better 
bone-graft contact than materials with comparatively small surface area (HOLMES 
and ROSER 1987, KASPERK et al. 1988). The surface area of each graft particle of 
BBM is considerably larger than that of porous bioceramics (e.g. HA) (HÄMMERLE 
et al. 1997). Therefore it might be a better grafting material. The second reason is 
that sintered HA particles, used as a space filler, are not substituted with normal 
bone because of their irresorbability. The use of porous HA blocks might result in 
mechanical fragile areas if used to fill defects in the cortex of long bones or thin 
mandibles (YAMAGUCHI et al. 1995). BBM is prone to osteoclastic resorption 
(PINHOLT et al. 1991, MERKX et al. 1999a, b) although other studies refute this 
(MANDELKOW et al. 1990, STASSEN et al. 1994, SKOGLUND et al. 1997, YOUNG et 
al. 1999). The resorption of BBM finally leads to a physiological substitution and 
remodelling which could be an advantage in favour for BBM. However studies 
about this specific subject are lacking so far.
6.4 CONCLUSION
Allogenic (ceramic) bone replacing materials as reported in literature, which all 
consist of calcium phosphate complexes, differ in origin (xenogenic, ceramic or 
coral), structure (pore size, absolute surface area and interconnections), chemical 
composition and finally (therefore) in resorbability. All these materials are supposed 
to provide a scaffold for bone ingrowth by means of osteoconduction which is 
enabled by the establishment of an environment allowing early migration of 
osteoblasts or osteoprogenitor cells into the area in which bone regeneration is 
intended (HÄMMERLE et al. 1997).
The successful regeneration of bone requires cells that will produce osteoid, 
an appropriate scaffold upon which the new bone is deposited and bioactive 
molecules to modulate the process. The host site should, of course, provide a 
vascular supply and nutrients. The transplant has to meet some mechanical 
requirements in order to approximate the mechanical properties of the bone that is 
replaced in the reconstructed area. The anatomy, functional loading, and chemical 
circumstances of a particular reconstruction dictate the exact mechanical
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requirements. Technology is now able to apply each of the required bone 
regeneration components separately (HOLLINGER 1993, YAZEMSKI et al. 1996).
Anorganic bone substitutes as solitary graft material, do not contribute to an 
early bone ingrowth and do not fulfil the requirements of an early functional 
loading. If it is necessary to use anorganic bone additives, the material that re­
establishes the integrity of the resorbed or injured maxillofacial skeleton should be a 
temporary material and be mixed with autogenous bone of cancellous origin. This is 
necessary because only then, the bone that is formed is soon able to bear functional 
load e.g. of dental implants, chewing or orthodontic forces. Consideration should be 
given to the intended clinical use of the materials. Prospective clinical studies 
should start to compare the healing response of different (anorganic) grafting 
materials at different acceptor sites in the maxillofacial area. This can provide 
information about the ideal graft composition, the optimal healing time, the value of 
anorganic additives, the effect of functional loading and, in the future, the impact of 
the use of osteoinductive proteins.
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7.1 GENERAL DISCUSSION
The primary aim of this study is to assess the healing of critically size bone defects 
using various types of autogenous bone grafts and composites of bovine bone 
mineral (BBM) and autogenous bone. A research model was developed over the 
frontal sinus, which purposely avoided the calvaria as experimental site because of 
the postulated osteogenic capacity of the dura. This modified model is likely to 
mimic the clinical situation better because bone grafts in oral- and maxillofacial 
(OMF) reconstructive surgery are often used in an area where the paranasal sinuses 
are exposed and nasal epithelium is lining the defect.
A prerequisite for successful grafting material is the presence of an 
appropriate scaffold allowing the ingrowth of bone to achieve the desired three­
dimensional structure. This could be the structure of the graft itself (block grafts) or 
trays made up from alloplastic materials. It also requires the presence of vital bone 
cells that produce osteoid and bioactive substances to modulate the process. The 
host site should, of course, provide an adequate vascular supply and nutrients. The 
graft usually has to fulfil some specific mechanical requirements as well, 
approximating the mechanical properties of the bone that is replaced in the 
reconstructed area. The anatomy and the functional loading of a particular 
reconstruction site dictate these mechanical requirements. At present, the 
technology is available to deal with each of the required bone healing components 
separately (HOLLINGER 1993, YASZEMSKI et al. 1996).
The size and form of the bony defect and the function of the location in 
question should determine the use of autogenous bone or alloplasts, alone or in 
combination (MISCH and DIETSH 1993). The choice and composition of the graft 
material should depend on the site and dimensions of the defect (FROUM et al. 
1998). In general, alloplasts can be used for small, non-critically size defects and 
three- to five-wall defects. Autogenous bone has to be added to the graft for one-, 
two-, or three-wall defects or relatively large, critical size defects. In general, the 
larger the defects, the greater the amount of autogenous bone required. Alveolar 
osseous defects in cleft palate patients or sinus floors to be augmented to receive 
implants, resemble a two- or three-wall defect.
The healing of cortical and cancellous bone block grafts in the present 
model, confirmed the observations made by other authors who used other recipient 
sites (BURCHARDT and ENNEKING 1978). Cancellous bone grafts revascularise and 
remodel faster than cortical grafts. Acceptance and incorporation of the bone grafts, 
however, were in all cases comparable to studies in calvarial defects (SCHMITZ and 
H o l l i n g e r  1986, A r d e n  and B u rg io  1992).
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For bridging or filling an osseous defect in the maxillofacial area particulate 
autogenous cancellous bone is as good as a cancellous block graft. It heals in the 
same way and in both cases there was hardly any difference to be seen between 
acceptor and donor bone tissue after 12 weeks. When there is no need for initial 
mechanical strength in two- or three-wall osseous defects it is probably easier to use 
particulate bone rather than have a bone block cut exactly to fit the defect. Particulate 
bone is conveniently obtained as surplus material when harvesting major grafts. 
Cancellous bone can be harvested by dissection of a part of the iliac crest, but it can 
also be obtained from the iliac crest or tibial plateau with a trephine. This reduces 
donor site morbidity and shortens operation time. Autogenous cancellous bone is still 
the material of choice when fast and reliable healing is wanted. The graft, however, 
lacks intrinsic mechanical strength and thus it is of limited use in case larger defects 
have to be bridged. This problem may be solved when three-dimensional scaffolds 
are developed that contain the graft and at the same time provide rigidity for the time 
needed for healing. Probably these scaffolds will come on the market in the near 
future.
Our study indicates that cortical bone chips are questionable as a solitary 
bone graft in the OMF region. Even after 24 weeks small areas filled with connective 
tissue were detectable lacking any osteoblastic activity, while at that time cancellous 
particulate grafts had healed completely. Cortical block grafts were still involved in a 
remodelling process after 24 weeks, while the cancellous block had completely been 
remodelled. These findings point to the fact that purely cortical autogenous bone 
grafts have only limited use in clinical practice. If their use is inevitable one should 
allow for enough time for the bone to be remodelled before mechanical loading of the 
graft is considered.
Alloplastic bone replacing materials consisting of calcium phosphate 
complexes, differ in origin (xenogenic, ceramic or coral), structure (pore size, 
absolute surface area and interconnections), chemical composition and, therefore, in 
resorbability. All these materials are supposed to provide a scaffold for bone 
ingrowth by means of osteoconduction, which requires an environment allowing 
early migration of osteoblasts or osteoprogenitor cells into the area in which bone 
regeneration is intended (HfeMMERLE et al. 1997). In the present study the use of a 
block of BBM resulted in centripetal ingrowth of newly woven bone at 3 weeks and 
the situation was stabilised after 6 weeks with an active, ongoing resorption of non­
integrated, non-functional BBM by multinucleated osteoclast-like cells. These 
findings are contrary to the results of THALLER et al. (1993) who did not see 
osteoclastic activity within 12 weeks after implantation of BBM in rabbit calvarial
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wounds, but found continuing reactive bone formation instead. KLINGE et al. 
(1992), also using rabbit calvaria, found osteoclasts in moderate amounts, but only 
close to the BBM implant-tissue interface indicating an active remodelling but not 
around the non-integrated isolated BBM. Although species differences between 
rabbits and goats cannot be excluded, the most plausible explanation for the 
conflicting results is that the model used in this study mimics the clinical situation 
more closely because the defects were lined by sinus epithelium instead of dura 
mater.
BBM granules as solitary implant in a critically size defect in contact with 
respiratory epithelium did hardly show osteoconduction but gave rise to extensive 
osteoclastic activity in the centre of the defect. This is probably due to the fact that 
the solitary particles tend to be mobile under the influence of outside forces. Jaw 
movements and respiration generate these forces. At the edges new bone pushed the 
granules forward as a ‘snowshovel’. A block of BBM in similar conditions, however, 
gives better results because in the centre of the defect a BBM block prevents fusion 
of the periosteum and the paranasal mucosa. Initially it gives rise to an area filled 
with loose connective tissue and remnants of BBM. Periosteum, paranasal mucosa 
and the margins of the defect delineate this area. Finally also the BBM in the centre 
will resorb and be replaced by fibrous tissue, but during that space maintaining 
period osteoid will be deposited by osteoconduction.
Thus, the current findings seem to indicate that BBM alone is not the graft 
material to be recommended for general use in OMF reconstructive surgery.
A composite graft, consisting of autogenous cancellous bone and BBM 
particles, however, shows more promising results, combining the advantages of 
each material alone and minimising their disadvantages. These composite grafts 
heal uneventfully within 12 weeks. All defects were bridged and integrated BBM 
particles were replaced to a large extent by newly formed bone due to physiological 
remodelling. At 24 weeks hardly any BBM particles were seen anymore. This 
mixed graft material certainly has something to offer. In selected cases it may be 
used to fill defects, minimising the need for a large volume of autogenous bone.
Cortical bone in a composite graft does not have a beneficial effect on 
healing and probably even has an opposite effect, as resorption of the cortical chips 
by osteoclasts seems to be induced by the presence of non-functional BBM.
A six months time interval is generally accepted for implants to be placed 
after sinus floor elevations and grafting. A rationale for the choice of this interval is 
the maturation of the grafted bone and thus, the expected better integration of the
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implants. The results of the present study and analysis of recent literature seem to 
indicate that this period may safely be shortened to three months.
The study on the eruption of premolars through particulate autogenous 
cortical bone, cancellous iliac crest bone or BBM, shows normal progress. These 
results, however, should be regarded with caution. The fact that BBM did not 
disturb eruption does not imply that other alloplastic materials would behave the 
same way. It is still recommended to use autogenous grafts for alveolo-palatal clefts 
in children in whom canines are supposed to erupt through the graft. BBM, 
however, may be mixed with these grafts if necessary. It will probably not hamper 
eruption of the canines.
The present study, as well as recent literature, shows that solitary anorganic 
bone grafts do not contribute to early bone ingrowth and do not fulfil the 
requirements for early functional loading (WHEELER et al. 1996, FROUM et al. 
1998). When selecting an alloplastic anorganic component for a possible composite 
grafts it has to be mixed with particulate autogenous bone.
7.2 CONCLUSIONS
• A critical size osseous defect over a frontal sinus in a young adult female 
goat, as used in the present study, can be used to assess graft healing.
• Healing and incorporation of an autogenous cancellous bone graft proceed 
irrespective of the way it is applied i.e. as block or particulate graft.
• Particulate cortical autogenous bone grafts used as implant material show 
less favourable results than particulate cancellous grafts.
• Particulate BBM shows no osteoconductive capacity but is prone to 
resorption. A BBM block graft, however, appears to be osteoconductive 
allowing bone ingrowth.
• BBM alone should not be used as a bone substitute in two- or three wall 
osseous critical size defects, but it may be added to particulate autogenous 
cancellous bone to form a composite graft.
• A composite graft consisting of a mixture of particulate BBM and 
autogenous cancellous bone combines the advantages of each material 
separately and minimises the disadvantages when used separately. In the 
experimental model used in this study these grafts heal uneventfully within 
12 weeks, giving rise to a solid vital mixture of bone/BBM. As time 
proceeds, the BBM will be completely replaced by new bone.
• A composite graft consisting of particulate BBM and autogenous cortical 
bone chips does not seem to be a good choice. Resorption of the cortical 
bone appears to be enhanced by the presence of BBM particles.
112
General Discussion
• Autogenous cancellous bone, cortical bone and BBM, when implanted into 
extraction sockets of deciduous teeth, have no inhibitory effect on eruption 
of the underlying mandibular premolars.
7.3 SUGGESTIONS FOR FUTURE RESEARCH
There is a need for prospective clinical and experimental studies to assess the 
efficacy of various composite grafts. Special attention has to be paid to the 
reduction of donor site morbidity because of harvest of autogenous bone. This 
implies a search for better resorbable scaffolds and the testing of growth factors 
such as BMP and autogenous growth factors in platelet rich plasma such as platelet 
derived growth factors (PDGF). The various indications for bone grafting in the 
OMF area require tailored solutions. This implies that research must also be 
focussed on experimental models mimicking the various clinical situations.
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Bone grafting in the oral and maxillofacial region with autogenous bone is a 
common procedure to reconstruct the extremely resorbed edentulous alveolar ridge, 
the cleft alveolus or osseous defects after ablative tumour surgery or trauma. The 
limited availability, the unpredictable resorption, the donor site morbidity, the need 
for a second operation area, the waste of bone material, the time consuming 
procedure and the increasing costs of hospitalisation, led to investigations for other, 
possibly effective alternatives.
The general purpose of this study was to gain insight into several aspects of 
bone grafting and graft healing in the maxillofacial area with emphasis on the 
application form, graft origin and the role of a commercially available bovine bone 
mineral (BBM) (Bio-Oss®, Geistlich-Pharma, Wolhusen, Switzerland) in oral and 
maxillofacial surgery. Most of the test models on bone grafting are performed in 
animal calvaria in which the dura mater plays a central role. In OMF surgery, 
however, the respiratory epithelium is involved, and therefore a standardized animal 
research model was developed in the maxillofacial skeleton in contact with a 
paranasal sinus. In a pilot study, trephined defects ( 0  14 mm) in the frontal bone 
overlaying a large frontal sinus on skeletally mature female goats, appeared to be of 
a critical size, which means that they will not heal spontaneously. This experiment 
model is used in chapter 2, 3 and 4 for answering questions concerning the 
regenerative response on autogenous cancellous and cortical bone grafts, and on a 
commercially available BBM. The materials were mutually compared in different 
application forms (block versus particulate) and composites (cancellous/BBM 
versus cortical/BBM graft).
A literature review (Chapter 1) exposed the mechanisms of bone-graft 
healing and the types of graft material (application forms, types and origins). In the 
first study (Chapter 2) the defects, in the newly developed model, were filled at 
random with a cortical bone block, a cancellous bone block, a spongeous BBM 
block cut into shape, or left empty. Histological evaluation showed that autogenous 
bone grafts were all accepted and incorporated in a similar way as in calvarial 
defects. Defects filled with BBM showed new bone formation at the margins of the 
defects and only little of the implant material was incorporated. Multinucleated 
osteoclast-like cells gradually resorbed most of the BBM. These results were in 
contrast to other studies. One of the reasons for early and continuous resorption of 
the non-incorporated BBM and the subsequent formation of fibrous tissue in the 
centre of the defect might be the continuous change in mechanical loading of the 
paranasal mucosa by breathing.
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The purpose of the second study (Chapter 3) was to compare the 
regenerative response of autogenous particulate cortical and cancellous bone and 
particulate BBM in the same setting as used in chapter 2. Autogenous particulate 
cancellous bone is the material of choice for bridging a bony defect in the 
maxillofacial area if mechanical strength is not needed. Particulate cancellous bone 
healed in the same way as cancellous bone blocks but has the advantage of an easier 
applicability. Particulate cortical bone is not reliable enough to be used as a solitary 
bone grafting material under these conditions. After 24 weeks only small 
fenestrations remained in the former defect. A cortical block as a solitary implant 
gave better results. Particulate BBM as solitary implant material in a critical size 
defect did not stimulate osteoconduction but gave rise to an extensive osteoclastic 
activity, probably stimulated by the mutual loose relation. A solid block of BBM is 
more reliable in a similar case. The centripetal ingrowth of newly woven bone in 
BBM, seen in the ‘block-study’ 3 weeks after implantation, could not be observed 
around particulate BBM. The new bone pushed the granules forward as by a 
'snowshovel' and no signs of osteoconduction were seen. To prevent this 
'snowshovel' effect, it seems better to implant a securely fitting block instead of 
particulate BBM.
In Chapter 4 the capacity of composite grafts consisting of either 
particulate cancellous or particulate cortical bone or BBM was evaluated. In 
conclusion, composite grafts consisting of autogenous cancellous bone/BBM yield 
good results, combining the advantages of each material in itself and reducing the 
disadvantages of each when used separately. Critical size defects in the 
maxillofacial area, overlaying a paranasal sinus, which are filled with this material 
heal uneventfully within 12 weeks. This is the same response as if particulate 
cancellous bone was implanted without an additive. Composite grafts consisting of 
cortical bone and BBM show less favourable results. These grafts induce 
osteoclasts, probably by the presence of non-functional BBM, resulting in 
resorption of the particulate cortical bone. More osteoid tissue was seen when pure 
cortical chips were used as a bone grafting material.
In Chapter 5 the effect of the use of different autogenous and BBM 
transplants on mandibular permanent premolar tooth eruption in beagle dogs was 
examined by radiology and histology. The deciduous first and third molar were ex­
tracted and their sockets over the second and fourth premolar were filled with 
autogenous particulate spongeous iliac crest bone, autogenous particulate cortical 
mandibular body bone, BBM granules (1-2 mm ), or left empty. The third premolar 
served as a control site. Standardized oblique lateral radiographs were made once a
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week. A number of co-ordinates of defined points and structures were determined 
by means of a co-ordinate digitising system. None of the premolars showed delay in 
eruption or disruption of crown and root development. Histological evaluation 
showed that particulate BBM was not resorbed or integrated in the alveolar bone, 
but pushed forward into the gingiva. The eruption curves of the permanent 
premolars in all groups were similar and bone transplantation had no inhibitory 
effect on their eruption.
A variety of anorganic alloplastic grafting materials are used in the OMF 
area to bridge an osseous defect or to create adequate bone volume for placement of 
endosseous implants. Because of the variation in literature data about the 
effectiveness of these materials in reconstructive procedures of the maxilla, in 
comparison with autogenous bone grafts, it is difficult to make protocols and select 
proper indications. A literature search in ‘Medline’ from 1989-1999 reported in 
Chapter 6 was performed to get a better insight in the pros and cons of the different 
modalities. Studies in which different graft materials were used in contact with the 
maxillary sinus and with histomorphometrical data were selected. Eight studies met 
the inclusion criteria: in 6 studies bone grafts were used in sinus floor elevation 
procedures and in 2 studies osteotomy gaps were bridged. It is concluded that 
autogenous bone gives the highest amount of osteoid volume, independent from the 
healing interval (1-24 months), application form (particulate versus block) and 
donor site (iliac crest versus chin). The results of inorganic calcium phosphate 
materials (bovine bone mineral or hydroxyapatite), solitary or as additive in 
composite grafts with autogenous particulate bone or demineralized freeze dried 
bone, show a large range of values, but in all cases the results are inferior to those of 
autogenous bone grafts. The data on anorganic calcium phosphate materials cannot 
be compared mutually, because of differences in healing interval, mixture ratios and 
histological procedures, but they do indicate that the use of composite grafts is to be 
preferred over the use of solitary anorganic bone mineral.
In the General Discussion (Chapter 7) the conclusions are listed as 
reported in the separate chapters. The future has to be focussed on prospective 
clinical and experimental studies to assess the efficacy of various composite grafts. 
Attention has to be paid to the role of different growth factors in bone healing in the 
OMF area.
119
Samenvatting
SAMENVATTING
Bottransplantatie in het Mond-, Kaak- en Aangezicht- (MKA) gebied met autoloog 
bot, is een standaardprocedure om bijvoorbeeld de extreem geresorbeerde edentate 
processus alveolaris, de aangeboren kaakspleet of botdefecten na oncologische 
chirurgie of ongevallen te reconstrueren. De beperkte hoeveelheid donorbot die 
geoogst kan worden, de onvoorspelbare resorptie van het transplantaat, de 
morbiditeit van de donorplaats, de noodzaak voor een tweede operatiegebied, de 
verkwisten van botmateriaal, de tijd nodig voor het winnen van het bot, en de 
toenemende kosten in de gezondheidszorg, zijn allemaal aanleidingen voor 
onderzoek naar alternatieven.
Het doel van deze studie was om inzicht te krijgen in de verschillende 
aspecten van bottransplantaties en botgenezing in het aangezichtsskelet met de 
nadruk op de toepassingsvorm, de oorsprong van het transplantaat en de rol van een 
commercieel verkrijgbaar runder botmineraal (BBM, Bio-Oss®, Geistlich-Pharma, 
Wolhusen, Zwitserland) in de MKA-chirurgie. De meeste dierexperimenten, 
uitgevoerd om materialen voor bottransplantatie te onderzoeken gebruiken het 
schedeldak als onderzoekslocatie, alwaar de dura mater een centrale rol speelt. In 
het MKA-gebied hebben we echter te maken met slijmvlies dat de luchtwegen 
bekleedt, het respiratoir trilhaarepitheel. Daarom hebben we een diermodel 
ontwikkeld waarbij het MKA-gebied wordt nagebootst door botdefecten te creëren 
in de voorwand van het os frontale over de sinus frontalis. In een pilotstudy, bleken 
botdefecten met een diameter van 14 mm of meer, gemaakt met een trepaanboor, bij 
jonge volwassen vrouwelijke geiten niet meer spontaan te genezen. Dergelijke 
defecten zijn dus van kritische grootte. Dit onderzoeksmodel werd gebruikt in 
hoofdstuk 2, 3 en 4 om vragen over de genezingscapaciteit van autoloog spongieus 
bot, autoloog corticaal bot en het commercieel verkrijgbare BBM te beantwoorden. 
Deze materialen werden onderling vergeleken met het accent op de applicatie vorm 
(botblok versus botmoes) en de mengvormen (spongieus/BBM versus 
corticaal/BBM).
In een literatuuroverzicht (Hoofdstuk 1) wordt een beschrijving gegeven 
van de transplantaatgenezing en de verschillende types van transplantaten 
(applicatie vorm, type transplantaat en origine). In de eerste studie (Hoofdstuk 2) 
werden de botdefecten, in het nieuw ontwikkelde diermodel, ‘at random ’ gevuld 
met een autoloog corticaal botblok, een autoloog spongieus botblok, een spongieus 
BBM blok of leeg gelaten. Histologische evaluatie toonde aan dat de autologe 
bottransplantaten werden geaccepteerd en op dezelfde wijze vast groeiden als in 
schedeldakdefecten. Defecten gevuld met BBM lieten een botingroei zien aan de
121
Chapter 8
randen van de defecten. Slechts een geringe hoeveelheid van het BBM werd 
geïncorporeerd. Multinucleaire osteoclast-achtige cellen resorbeerden het BBM 
langzaam. Een van de redenen voor deze vroege en continue resorptie van het niet 
geïncorporeerde BBM en de daaropvolgende bindweefselvorming in het centrum 
van het botdefect zou de continue mechanische belasting van de paranasale mucosa 
kunnen zijn, veroorzaakt door aan de ademhaling gerelateerde factoren.
Het doel van de tweede studie (Hoofdstuk 3) was het bestuderen van de 
regeneratieve capaciteit van autoloog spongieus, corticaal en BBM botmoes in 
hetzelfde onderzoeksmodel als gebruikt in hoofdstuk 2. Autoloog spongieus 
botmoes is het te verkiezen materiaal om een botdefect in het MKA-gebied te 
overbruggen wanneer er geen mechanische ondersteuning nodig is. Autoloog 
spongieus botmoes geneest op dezelfde wijze als autologe spongieuze botblokken 
maar heeft als voordeel dat het makkelijker aan te brengen is. Een corticaal botblok 
als solitair transplantaat onder dezelfde omstandigheden geeft een beter resultaat 
dan corticaal botmoes. Na 24 weken werd het defect niet egaal met nieuw bot 
overbrugd maar bleven er uiteindelijk perforaties zonder genezingstendens over.
BBM botpartikels als solitair implantatiemateriaal in een botdefect met een 
kritische grootte was geen stimulans voor botingroei maar liet een uitgebreide 
osteoclastische activiteit zien, mogelijk gestimuleerd door de onderlinge 
beweeglijkheid. Een BBM botblok is betrouwbaarder. De botingroei vanaf de 
randen, die gezien werd in de ‘blokstudie’ bij een BBM-blok (hoofdstuk 2), 3 
weken na implantatie, werd niet gezien in de ‘moesstudie’ bij BBM partikels. Het 
nieuw gevormde bot duwt de BBM partikels opzij zoals een ‘sneeuwschuiver’, 
zonder tekenen van botingroei tussen de partikels. Om dit ‘sneeuwschuiver’ effect 
te voorkomen lijkt het beter een exact passend BBM blok te gebruiken dan BBM 
partikels.
In Hoofdstuk 4 werd de genezingscapaciteit van gemengde transplantaten 
geëvalueerd (autoloog spongieus botmoes/BBM partikels versus autoloog corticaal 
botmoes/BBM partikels). Geconcludeerd kan worden dat een mengsel van autoloog 
spongieus bot en BBM goede resultaten geeft, waarbij de voordelen van beide 
materialen afzonderlijk worden gecombineerd en de afzonderlijke nadelen worden 
gereduceerd. Botdefecten met een kritische grootte in het MKA-gebied in contact 
met een paranasale sinus, gevuld met dit mengsel genezen zonder complicatie 
binnen 12 weken. Dit is even snel als de genezing van botdefecten wanneer 
autoloog spongieus zonder BBM wordt gebruikt. Een mengsel van autoloog 
corticaal bot met BBM geeft een minder resultaat. Deze mengsels stimuleren 
osteoclasten, mogelijk door het afunctionele BBM, wat resulteert in een
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progressieve resorptie van het corticale botmoes. Meer osteoid weefsel werd gezien 
wanneer er puur corticaal botmoes als transplantatie materiaal werd gebruikt.
Het effect van het gebruik van de twee verschillende autologe materialen en 
BBM op de tanderuptie van blijvende premolaren in de mandibula van beagle 
honden werd onderzocht in Hoofdstuk 5. De eerste en derde melkkies werden op 
een leeftijd van 10 weken getrokken waarna de ontstane botdefecten over de 
blijvende tweede en vierde premolaar werden opgevuld met autoloog corticaal 
botmoes, autoloog spongieus botmoes, BBM granulaat of leeg werden gelaten. De 
derde blijvende premolaar diende als controle element. Wekelijks werden 
gestandaardiseerde röntgenfoto’s genomen. Aan de hand van vaste referentiepunten 
werd middels een gedigitaliseerd systeem de verplaatsing tijdens de tanderuptie 
vastgelegd. Geen van de premolaren vertoonde een vertraging van de doorbraak of 
een verstoring van de kroon- of wortelontwikkeling. Histologische evaluatie liet 
zien dat de BBM partikels niet resorbeerden noch integreerden in het alveolaire bot, 
maar dat de partikels werden verplaatst naar de gingiva. De eruptiecurven van de 
blijvende premolaren in alle groepen vertoonden geen onderlinge verschillen.
In de MKA-chirurgie wordt een verscheidenheid aan anorganische en 
synthetische, biologisch inerte (alloplastische) transplantatie materialen gebruikt om 
botdefecten te overbruggen of om voldoende botvolume te creëren voor het plaatsen 
van tandwortel implantaten. Vanwege de variatie in de literatuur over de 
effectiviteit van deze materialen in vergelijking met autologe materialen, met name 
in reconstructieve procedures van de bovenkaak, is het soms moeilijk protocollen te 
ontwikkelen en de juiste indicaties te selecteren. In Hoofdstuk 6 wordt een analyse 
gegeven van de literatuur, gerefereerd in ‘Medline’ van 1989-1999 met betrekking 
tot de voor- en nadelen van de verschillende modaliteiten. Studies waarin 
verschillende transplantatie materialen waren gebruikt in contact met de sinus 
maxillaris en waarvan histomorfometrische gegevens waren gerapporteerd werden 
geselecteerd. Acht studies werden in de analyse betrokken: in 6 studies werden 
bottransplantaten geplaatst voor sinusbodem-elevaties en in 2 studies ter 
overbrugging van osteotomie defecten. Over het algemeen kan worden 
geconcludeerd dat autoloog bot uiteindelijk de grootste hoeveelheid botvolume 
geeft, onafhankelijk van de genezingsperiode (1-24 maanden), wijze van 
aanbrengen (botmoes versus botblok) en donorlocatie (crista iliaca versus kin). De 
resultaten van anorganische calcium fosfaat materialen (BBM of hydroxyapatiet), 
solitair of in gemengde vorm met autoloog botmoes of gedemineraliseerd allogeen 
bot, vertoonden een grote variatie in de hoeveelheid osteoid dat werd afgezet. In alle 
gevallen waren deze waarden lager dan die bij de autologe bottransplantaten. De
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data van de verschillende anorganische materialen kunnen niet eenvoudig met 
elkaar vergeleken worden vanwege de verscheidenheid van genezingsinterval, de 
mengverhoudingen en de verschillende histologische procedures. Zij geven wel aan 
dat het gebruik van mengsels van autoloog bot met anorganische materialen de 
voorkeur verdient boven het gebruik van solitaire anorganische bot mineralen.
In een afsluitende discussie (Hoofdstuk 7) worden conclusies getrokken uit 
het experimentele werk. De toekomst zal gericht moeten zijn op prospectieve 
klinische en experimentele onderzoeken om de effectiviteit van de verschillende 
samengestelde transplantaten vast te stellen. Daarbij zal ook aandacht moeten 
worden besteed aan de rol van verschillende groeifactoren bij botgenezing in het 
MKA-gebied.
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hand. Als een coach heb jij een ‘clinicus practicus’ op het wetenschappelijke pad 
gehouden. De stappen gingen niet altijd vanzelf! Dank voor je nooit aflatende steun.
Staf en medewerkers van de afdeling Mond- en Kaakchirurgie van het 
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Biologie, dank voor de hulp bij het uitvoeren van de experimenten en het bewerken 
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Met mijn paranimfen Huib en Luc heb ik de eerste stappen gezet 
respectievelijk als student en assistent. Veel ervaringen hebben we gedeeld.
Mijn ouders wil ik bedanken voor hun warme belangstelling tijdens deze 
‘fase’. Dat ik met mijn vader een speciale band heb, moge duidelijk zijn: ‘de appel 
is niet ver van de boom gevallen’!
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Fig 2.3a BBM 6 weeks after implantation. 
Margin o f a defect: osteoconduction in BBM  
sponge (x40). BBM = Incorporated particle o f 
Bovine Bone Mineral, Arrows = Margin o f the 
defect.
Fig 2.3b BBM 6 weeks after implantation 
Centre o f the same defect as 3a: osteoclasts 
around BBM (x40). BBM = Bovine Bone 
Mineral, Arrows = Active osteoclasts 
around non-incorporated BBM particle.
Fig 2.4 Undecalcified section o f cancellous 
bone graft 12 weeks after transplantation. 
Labelling reflecting a high remodelling activity. 
The original spongious structure can be 
recognized (x25).
Fig 2.5 Undecalcified section o f cortical 
bone graft 12 weeks after transplantation. 
More regular labelling pattern with 
concentric circles over the whole graft 
reflecting a slow remodelling process. Mark 
the difference with fig. 2.4 (x25).
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Fig 2.6 BBM 12 weeks after implantation. 
Extensive osteoclastic activity around remnants 
o f non-integrated, partly degraded BBM in the 
centre o f the defect (x25). BBM = Bovine Bone 
Mineral, Arrows = Osteoclasts, B = Bone
Fig 2.7 Control defect 24 weeks after 
operation. The non-bridged defect showed 
variable amounts o f bone deposition, 
extending to a considerable distance o f the 
margins. Resting osteoblasts or lining cells 
on the bone surface indicated a stable phase 
(x5). N  = Nasal side, P  = Periosteal side, B  
= Bony margin o f the defect
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Fig 2.8 BBM 24 weeks after implantation. 
Integrated BBM near the margin o f a defect. No 
remodelling activity is seen around these 
particles. (x25). Arrows = Bovine Bone Mineral
Fig 3.5 Cancellous bone chips, 12 weeks after 
implantation. The structure o f the chips is still 
recognizable in the irregular trabeculae o f new  
bone (orig. magn. x25). Arrows = former chips 
with empty lacunae
Fig 3.4 Cancellous particulate bone, 3 
weeks after implantation, embedded in 
young bone delineated by osteoblasts, (orig. 
magn. x25).
Fig 3.6 BBM 12 weeks after implantation. 
Incorporated particles o f BBM are involved 
in the physiologic remodelling process 
orig. Magn.
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Fig 4.2 Cancellous/BBM graft 3 weeks after 
implantation. An active bone formation 
sprouted from solitaire cancellous bone chips. 
The BBM particles are surrounded by 
multinucleated cells (orig. magn. x25), B = 
Bovine bone mineral; C = Cancellous bone 
chip surrounded by new bone; arrow = active 
bone formation.
Fig 4.3 Cortical/BBM graft 3 weeks after 
implantation. Osteoclastic activity was found 
around individual cortical and BBM chips 
(orig. magn. x25). No new bone formation was 
seen around the original cortical chips. B = 
Bovine bone mineral; C = cortical bone chip; 
arrow = multinucleated cells.
Fig 4.4 Cancellous/BBM graft 6 weeks after 
implantation. Integrated BBM surrounded by 
new bone in which the former cancellous and 
the BBM particles could be recognized (orig. 
magn. x25). B = Bovine bone mineral; arrow 
= former cancellous bone chip.
F ig 4.5 Cortical/BBM graft 6 weeks after 
implantation. In the centre o f the defects 
osteoclast-like cells surrounded the cortical 
chips and the BBM granules. No bone 
deposition was seen. (orig. magn. x25). B= 
Bovine bone mineral; arrow = multinucleated 
cells.
Fig 4.6 Cancellous/BBM graft 12 weeks after 
implantation. The BBM particles are 
integrated in more compact bone than in Fig. 
4.4. The original structure o f the cancellous 
chips could hardly be recognized anymore 
(orig. Magn. x25). B = Bovine bone mineral.
Fig 4.7 Cortical/BBM graft 12 weeks after 
implantation. In all cases BBM granules in the 
central area were embedded in mature fibrous 
tissue surrounded by multinucleated cells (orig. 
magn. x25). B = Bovine bone mineral; F  = 
fibrous tissue.
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Fig 5.5 Photomicrograph o f cortical bone 
chips four weeks after transplantation at an 
age o f 18 weeks showing the non-vital 
aspect o f the bone chips with only some 
osteocytes in the lacunae. (Haematoxylin 
and Eosin; x40). CBC = cortical bone chips, 
AB = alveolar bone
Fig 5.6 Photomicrograph o f spongious bone 
chips four weeks after transplantation at an 
age o f 18 weeks after transplantation showing 
the incorporated bone chips with osteons 
among them. Arrow indicates remnants o f 
cartilage (Haematoxylin and Eosin; x40). SBC 
= spongious bone chips, O = new osteon
Fig 5.7 Photomicrograph o f BBM particles F ig 5.8 Detail o f fig  5.7. Osteoclast-like cells 
four weeks after transplantation at an age o f surrounding the particles (Haematoxylin and 
18 weeks showing the connective tissue layer Eosin; x40) 
around them without signs o f inflammation.
Arrow indicates BBM particle 
(Haematoxylin and Eosin; x10). T = tooth,
AB = alveolar bone
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Fig 5.9 Photomicrograph o f BBM particles 
16 weeks after transplantation at an age o f 30 
weeks. Arrow indicates BBM particle 
(Haematoxylin and Eosin; x10). T = tooth, AB 
= alveolar bone
Fig 5.10 Photomicrograph o f one BBM  
particle 16 weeks after transplantation at an 
age o f 30 weeks showing the thin fibrous 
sheet around the particle lying in connective 
tissue, not integrated in the alveolar bone. 
Arrow indicates BBM particle. 
(Haematoxylin and Eosin; x40)
132
